activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1507277	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Kd	nM	2400.0	CHEMBL3290	Homo sapiens	Kd	uM	2.4
	1507277	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Kd	nM	2400.0	CHEMBL3290	Homo sapiens	Kd	uM	2.4
	1507278	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	IC50	nM	1200.0	CHEMBL3290	Homo sapiens	IC50	uM	1.2
	1507279	CHEMBL875576	Inhibition of ephrin-B1-mediated EPH receptor B2 autophosphorylation	F	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Inhibition	%	107.6	CHEMBL3290	Homo sapiens	Inhibition	%	107.6
	1507280	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	6800.0	CHEMBL3290	Homo sapiens	Kd	uM	6.8
	1507281	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	7800.0	CHEMBL3290	Homo sapiens	IC50	uM	7.8
	1507282	CHEMBL875576	Inhibition of ephrin-B1-mediated EPH receptor B2 autophosphorylation	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	86.5	CHEMBL3290	Homo sapiens	Inhibition	%	86.5
	1507283	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Kd	nM	8100.0	CHEMBL3290	Homo sapiens	Kd	uM	8.1
	1507284	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	IC50	nM	10200.0	CHEMBL3290	Homo sapiens	IC50	uM	10.2
	1507285	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Kd	nM	58400.0	CHEMBL3290	Homo sapiens	Kd	uM	58.4
	1507286	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	IC50	nM	86000.0	CHEMBL3290	Homo sapiens	IC50	uM	86.0
	1507287	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	Kd	nM	6200.0	CHEMBL3290	Homo sapiens	Kd	uM	6.2
	1507288	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	8500.0	CHEMBL3290	Homo sapiens	IC50	uM	8.5
Not Determined	1507289	CHEMBL826482	Equilibrium binding constant for EPH receptor B2; ND = Not determined	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191		Kd	nM		CHEMBL3290	Homo sapiens	Kd	uM	
	1507290	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC	Outside typical range	CHEMBL71191	=	IC50	nM	110000.0	CHEMBL3290	Homo sapiens	IC50	uM	110.0
	1507291	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	Brc1cccc(Nc2ncnc3cc4[nH]cnc4cc23)c1		CHEMBL66031	=	Kd	nM	15200.0	CHEMBL3290	Homo sapiens	Kd	uM	15.2
	1507292	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	Brc1cccc(Nc2ncnc3cc4[nH]cnc4cc23)c1		CHEMBL66031	=	IC50	nM	22000.0	CHEMBL3290	Homo sapiens	IC50	uM	22.0
Not Determined	1507294	CHEMBL826999	Equilibrium binding constant for EPH receptor B2; ND = Not determined	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762		Kd	nM		CHEMBL3290	Homo sapiens	Kd	uM	
	1507295	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1	Outside typical range	CHEMBL188762	=	IC50	nM	180000.0	CHEMBL3290	Homo sapiens	IC50	uM	180.0
	1507296	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	CNc1ccc2c(Nc3cccc(Br)c3)ncnc2c1		CHEMBL92812	=	Kd	nM	21900.0	CHEMBL3290	Homo sapiens	Kd	uM	21.9
	1507297	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	CNc1ccc2c(Nc3cccc(Br)c3)ncnc2c1		CHEMBL92812	=	IC50	nM	34000.0	CHEMBL3290	Homo sapiens	IC50	uM	34.0
	1507298	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Kd	nM	36500.0	CHEMBL3290	Homo sapiens	Kd	uM	36.5
	1507299	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	52000.0	CHEMBL3290	Homo sapiens	IC50	uM	52.0
	1507300	CHEMBL826985	Equilibrium binding constant for EPH receptor B2	B	CN(C)c1ccc(/C=C2/C(=O)Nc3ccccc32)cc1		CHEMBL296455	=	Kd	nM	19500.0	CHEMBL3290	Homo sapiens	Kd	uM	19.5
	1507301	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	CN(C)c1ccc(/C=C2/C(=O)Nc3ccccc32)cc1		CHEMBL296455	=	IC50	nM	27500.0	CHEMBL3290	Homo sapiens	IC50	uM	27.5
	1507302	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	O=C(Nc1c(-c2ccccc2)nc2ncccn12)c1ccc(Cl)cc1		CHEMBL426989	=	IC50	nM	88000.0	CHEMBL3290	Homo sapiens	IC50	uM	88.0
	1507303	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	O=C1C=C(Nc2ccc(O)cc2)C(=O)c2ccccc21		CHEMBL1631459	=	IC50	nM	38000.0	CHEMBL3290	Homo sapiens	IC50	uM	38.0
	1507304	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1ccccc1NC(=O)CSc1nnc2c3ccccc3n(C)c2n1	Outside typical range	CHEMBL191636	=	IC50	nM	136000.0	CHEMBL3290	Homo sapiens	IC50	uM	136.0
	1507305	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1ccc(/C=C2\SC(Nc3ccc(O)cc3)=NC2=O)cc1OC	Outside typical range	CHEMBL362977	=	IC50	nM	220000.0	CHEMBL3290	Homo sapiens	IC50	uM	220.0
	1507306	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1ccc(NC2=NC(=O)/C(=C/c3ccco3)S2)cc1	Outside typical range	CHEMBL365327	=	IC50	nM	230000.0	CHEMBL3290	Homo sapiens	IC50	uM	230.0
	1507307	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	C/C(=N\NC(=O)c1sc(NS(=O)(=O)c2ccccc2)nc1C)c1sc(N)nc1C		CHEMBL192044	=	IC50	nM	94000.0	CHEMBL3290	Homo sapiens	IC50	uM	94.0
	1507308	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	COc1ccc(NC(=S)N(CCc2c(C)[nH]c3ccccc23)Cc2ccncc2)cc1	Outside typical range	CHEMBL193891	=	IC50	nM	250000.0	CHEMBL3290	Homo sapiens	IC50	uM	250.0
	1507309	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	Cc1[nH]c2ccccc2c1CCN(Cc1ccncc1)/C(S)=N/c1ccc(F)cc1	Outside typical range	CHEMBL191630	=	IC50	nM	104000.0	CHEMBL3290	Homo sapiens	IC50	uM	104.0
	1507310	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	Cc1[nH]c2ccc(F)cc2c1CCN(Cc1ccncc1)/C(S)=N/c1ccc(Cl)cc1		CHEMBL191403	=	IC50	nM	65000.0	CHEMBL3290	Homo sapiens	IC50	uM	65.0
	1507311	CHEMBL875576	Inhibition of ephrin-B1-mediated EPH receptor B2 autophosphorylation	F	Cc1[nH]c2ccc(F)cc2c1CCN(Cc1ccncc1)/C(S)=N/c1ccc(Cl)cc1		CHEMBL191403	=	Inhibition	%	25.8	CHEMBL3290	Homo sapiens	Inhibition	%	25.8
	1507312	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	CC(C)OCCCNC(=O)CCc1nc(-c2ccccc2F)no1	Outside typical range	CHEMBL193115	=	IC50	nM	201000.0	CHEMBL3290	Homo sapiens	IC50	uM	201.0
	1507313	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	c1cn(CCCNc2[nH]cnc3ncnc2-3)cn1		CHEMBL192767	=	IC50	nM	5200.0	CHEMBL3290	Homo sapiens	IC50	uM	5.2
	1507314	CHEMBL875576	Inhibition of ephrin-B1-mediated EPH receptor B2 autophosphorylation	F	c1cn(CCCNc2[nH]cnc3ncnc2-3)cn1		CHEMBL192767	=	Inhibition	%	17.0	CHEMBL3290	Homo sapiens	Inhibition	%	17.0
	1507410	CHEMBL827811	Inhibition of EPH receptor B2 using ELISA	B	c1ccc(CNc2[nH]cnc3ncnc2-3)nc1	Outside typical range	CHEMBL365356	=	IC50	nM	106000.0	CHEMBL3290	Homo sapiens	IC50	uM	106.0
	1507411	CHEMBL875576	Inhibition of ephrin-B1-mediated EPH receptor B2 autophosphorylation	F	c1ccc(CNc2[nH]cnc3ncnc2-3)nc1		CHEMBL365356	=	Inhibition	%	22.5	CHEMBL3290	Homo sapiens	Inhibition	%	22.5
Not Determined	1507412	CHEMBL826486	Inhibition of EPH receptor B2 using ELISA; ND = Not determined	B	Cc1ccccc1ONc1[nH]cnc2ncnc1-2		CHEMBL373112		IC50	nM		CHEMBL3290	Homo sapiens	IC50	uM	
	1507413	CHEMBL875576	Inhibition of ephrin-B1-mediated EPH receptor B2 autophosphorylation	F	Cc1ccccc1ONc1[nH]cnc2ncnc1-2		CHEMBL373112	=	Inhibition	%	-5.9	CHEMBL3290	Homo sapiens	Inhibition	%	-5.9
Not Determined	1507414	CHEMBL826486	Inhibition of EPH receptor B2 using ELISA; ND = Not determined	B	COC(=O)c1ccc(Nc2[nH]cnc3ncnc2-3)cc1		CHEMBL195744		IC50	nM		CHEMBL3290	Homo sapiens	IC50	uM	
Not Determined	1507415	CHEMBL826486	Inhibition of EPH receptor B2 using ELISA; ND = Not determined	B	COc1ccc(Nc2[nH]cnc3ncnc2-3)cc1OC		CHEMBL365342		IC50	nM		CHEMBL3290	Homo sapiens	IC50	uM	
Not Determined	1507416	CHEMBL826486	Inhibition of EPH receptor B2 using ELISA; ND = Not determined	B	COc1ccc(Nc2[nH]cnc3ncnc2-3)c(OC)c1		CHEMBL371813		IC50	nM		CHEMBL3290	Homo sapiens	IC50	uM	
Not Determined	1507417	CHEMBL826486	Inhibition of EPH receptor B2 using ELISA; ND = Not determined	B	FC(F)Oc1ccc(Nc2[nH]cnc3ncnc2-3)cc1		CHEMBL192233		IC50	nM		CHEMBL3290	Homo sapiens	IC50	uM	
Not Determined	1507418	CHEMBL826486	Inhibition of EPH receptor B2 using ELISA; ND = Not determined	B	C1=Nc2ccccc2C1CCNc1[nH]cnc2ncnc1-2		CHEMBL362958		IC50	nM		CHEMBL3290	Homo sapiens	IC50	uM	
Not Determined	1507419	CHEMBL826486	Inhibition of EPH receptor B2 using ELISA; ND = Not determined	B	CCCCN(CCNc1[nH]cnc2ncnc1-2)c1ccccc1		CHEMBL192814		IC50	nM		CHEMBL3290	Homo sapiens	IC50	uM	
	1727570	CHEMBL859759	Inhibition of human EphB2 at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC	Outside typical range	CHEMBL210833	=	Inhibition	%	-11.0	CHEMBL3290	Homo sapiens	Inhibition	%	-11.0
	2025137	CHEMBL886964	Inhibition of human EphB2 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	114.0	CHEMBL3290	Homo sapiens	Inhibition	%	114.0
	2025303	CHEMBL886964	Inhibition of human EphB2 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	125.0	CHEMBL3290	Homo sapiens	Inhibition	%	125.0
	2025304	CHEMBL886964	Inhibition of human EphB2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	114.0	CHEMBL3290	Homo sapiens	Inhibition	%	114.0
	2025305	CHEMBL886964	Inhibition of human EphB2 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	110.0	CHEMBL3290	Homo sapiens	Inhibition	%	110.0
	2147254	CHEMBL921844	Activity of human EphB2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	69.0	CHEMBL3290	Homo sapiens	Activity	%	69.0
	2167617	CHEMBL932337	Inhibition of EphB2	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	50.0	CHEMBL3290	Homo sapiens	IC50	uM	0.05
	2182422	CHEMBL941321	Inhibition of EphB2 at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	11.0	CHEMBL3290	Homo sapiens	INH	%	11.0
	2187845	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL448652	=	Kd	nM	6000.0	CHEMBL3290	Homo sapiens	Kd	uM	6.0
	2187846	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O		CHEMBL508295	>	Kd	nM	50000.0	CHEMBL3290	Homo sapiens	Kd	uM	50.0
	2187847	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL504627	>	Kd	nM	50000.0	CHEMBL3290	Homo sapiens	Kd	uM	50.0
	2187848	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL505364	>	Kd	nM	50000.0	CHEMBL3290	Homo sapiens	Kd	uM	50.0
	2187849	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL453443	>	Kd	nM	50000.0	CHEMBL3290	Homo sapiens	Kd	uM	50.0
	2187850	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL451203	>	Kd	nM	50000.0	CHEMBL3290	Homo sapiens	Kd	uM	50.0
	2187851	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL504700	>	Kd	nM	50000.0	CHEMBL3290	Homo sapiens	Kd	uM	50.0
	2187852	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL508644	=	Kd	nM	6000.0	CHEMBL3290	Homo sapiens	Kd	uM	6.0
	2187853	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL526325	=	Kd	nM	3000.0	CHEMBL3290	Homo sapiens	Kd	uM	3.0
	2187854	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL526907	=	Kd	nM	11000.0	CHEMBL3290	Homo sapiens	Kd	uM	11.0
	2187855	CHEMBL981909	Binding affinity at human EphB2 receptor by isothermal titration calorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O		CHEMBL525059	>	Kd	nM	50000.0	CHEMBL3290	Homo sapiens	Kd	uM	50.0
	2206983	CHEMBL966755	Inhibition of EphB2	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	uM	10.0
	2470177	CHEMBL1034126	Inhibition of EPHB2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3290	Homo sapiens	INH	%	10.0
Not Evaluated	2476661	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2476864	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2478703	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3290	Homo sapiens	Activity		
	2479542	CHEMBL988936	Binding affinity to human EPHB2	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	7.0	CHEMBL3290	Homo sapiens	Kd	nM	7.0
Not Evaluated	2479761	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2480558	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL3290	Homo sapiens	Activity		
	2480760	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.15	CHEMBL3290	Homo sapiens	Activity	%	0.15
	2511955	CHEMBL969675	Inhibition of human EphB2 at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	104.0	CHEMBL3290	Homo sapiens	Activity	%	104.0
	2560141	CHEMBL986510	Inhibition of EphB2 by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	uM	10.0
	2560145	CHEMBL986520	Inhibition of EphB2 at 10 uM by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	Inhibition	%	44.3	CHEMBL3290	Homo sapiens	INH	%	44.3
Not Evaluated	2577382	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3290	Homo sapiens	Activity		
	2593587	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	31.9	CHEMBL3290	Homo sapiens	Activity	%	31.9
Active	2593790	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2593853	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3290	Homo sapiens	Activity		
Active	2594056	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2594999	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3290	Homo sapiens	Activity		
	2595268	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	1.65	CHEMBL3290	Homo sapiens	Activity	%	1.65
Not Evaluated	2596196	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2596399	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2597668	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3290	Homo sapiens	Activity		
Not Evaluated	2597871	CHEMBL1024913	Binding affinity to human EPHB2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3290	Homo sapiens	Activity		
	2719522	CHEMBL1060003	Inhibition of EphB2	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(NC(=O)c4ccno4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL559058	=	EC50	nM	40.0	CHEMBL3290	Homo sapiens	EC50	nM	40.0
	2719523	CHEMBL1060003	Inhibition of EphB2	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1cncc(C(N)=O)c1		CHEMBL552425	=	EC50	nM	40.0	CHEMBL3290	Homo sapiens	EC50	nM	40.0
Active	2719541	CHEMBL1059991	Inhibition of EphB2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
	2719563	CHEMBL1060001	Inhibition of ephrin-B1-induced autophosphorylation of EphB2 expressed in human U87 cells after 1 hr by Western blot analysis	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1cncc(C(N)=O)c1		CHEMBL552425	=	EC50	nM	100.0	CHEMBL3290	Homo sapiens	EC50	nM	100.0
	2721601	CHEMBL1057429	Inhibition of EphB2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	2905914	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905915	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905916	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	130.0	CHEMBL3290	Homo sapiens	Kd	nM	130.0
	2905917	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905918	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	440.0	CHEMBL3290	Homo sapiens	Kd	nM	440.0
	2905919	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905920	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905921	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905922	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2700.0	CHEMBL3290	Homo sapiens	Kd	nM	2700.0
	2905923	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905924	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905925	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.39	CHEMBL3290	Homo sapiens	Kd	nM	0.39
	2905926	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905927	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905928	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905929	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905930	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905931	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905932	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905933	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905934	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905935	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905936	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905937	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905938	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905939	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905940	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905941	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905942	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905943	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905944	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905945	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1900.0	CHEMBL3290	Homo sapiens	Kd	nM	1900.0
	2905946	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2100.0	CHEMBL3290	Homo sapiens	Kd	nM	2100.0
	2905947	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905948	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905949	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905950	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	2905951	CHEMBL1063709	Binding constant for EPHB2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	440.0	CHEMBL3290	Homo sapiens	Kd	nM	440.0
	2921351	CHEMBL1053714	Inhibition of EPHB2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	6.1	CHEMBL3290	Homo sapiens	Activity	%	6.1
	2926280	CHEMBL1046778	Inhibition of EphB2 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	1.2	CHEMBL3290	Homo sapiens	IC50	nM	1.2
	2938510	CHEMBL1041355	Inhibition of EPH-B2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	3052599	CHEMBL1037575	Residual activity of EPHB2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	72.0	CHEMBL3290	Homo sapiens	Residual activity	%	72.0
	3053908	CHEMBL1044308	Residual activity of EPHB2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	16.0	CHEMBL3290	Homo sapiens	Residual activity	%	16.0
	3054160	CHEMBL1040628	Residual activity of EPHB2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	99.0	CHEMBL3290	Homo sapiens	Residual activity	%	99.0
	3055447	CHEMBL1037575	Residual activity of EPHB2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	86.0	CHEMBL3290	Homo sapiens	Residual activity	%	86.0
	3055699	CHEMBL1044308	Residual activity of EPHB2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	18.0	CHEMBL3290	Homo sapiens	Residual activity	%	18.0
	3057004	CHEMBL1040628	Residual activity of EPHB2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL3290	Homo sapiens	Residual activity	%	97.0
	3058324	CHEMBL1037575	Residual activity of EPHB2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL3290	Homo sapiens	Residual activity	%	98.0
	3058576	CHEMBL1044308	Residual activity of EPHB2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	35.0	CHEMBL3290	Homo sapiens	Residual activity	%	35.0
	3072922	CHEMBL1040628	Residual activity of EPHB2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	98.0	CHEMBL3290	Homo sapiens	Residual activity	%	98.0
	3213804	CHEMBL1108391	Inhibition of EPHB2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	103.0	CHEMBL3290	Homo sapiens	INH	%	103.0
	3224812	CHEMBL1099649	Inhibition of EPHB2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3225062	CHEMBL1099649	Inhibition of EPHB2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3331924	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3333339	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3334744	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3336164	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3337519	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3337768	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3339102	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3340404	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3340692	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3342108	CHEMBL1169214	Inhibition of EPHB2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	3358559	CHEMBL1174404	Inhibition of EPHB2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.1	CHEMBL3290	Homo sapiens	INH	%	0.1
	3359001	CHEMBL1174404	Inhibition of EPHB2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.6	CHEMBL3290	Homo sapiens	INH	%	0.6
	3359775	CHEMBL1177628	Inhibition EphB2 at 10 uM	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	Inhibition	%	11.5	CHEMBL3290	Homo sapiens	INH	%	11.5
	3359776	CHEMBL1177627	Inhibition EphB2	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	uM	10.0
	3443389	CHEMBL1244422	Inhibition of EPHB2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	97.0	CHEMBL3290	Homo sapiens	INH	%	97.0
	3443606	CHEMBL1244422	Inhibition of EPHB2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	86.0	CHEMBL3290	Homo sapiens	INH	%	86.0
	3444761	CHEMBL1244422	Inhibition of EPHB2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	91.0	CHEMBL3290	Homo sapiens	INH	%	91.0
	3445385	CHEMBL1244422	Inhibition of EPHB2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	72.0	CHEMBL3290	Homo sapiens	INH	%	72.0
	3445602	CHEMBL1244422	Inhibition of EPHB2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	3445811	CHEMBL1244422	Inhibition of EPHB2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	92.0	CHEMBL3290	Homo sapiens	INH	%	92.0
	3446001	CHEMBL1244422	Inhibition of EPHB2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	77.0	CHEMBL3290	Homo sapiens	INH	%	77.0
	3446244	CHEMBL1244584	Inhibition of EPHB2	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	8.5	CHEMBL3290	Homo sapiens	IC50	nM	8.5
	3446264	CHEMBL1244584	Inhibition of EPHB2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	4.4	CHEMBL3290	Homo sapiens	IC50	nM	4.4
	3448418	CHEMBL1244821	Binding affinity to EPHB2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	3448743	CHEMBL1244821	Binding affinity to EPHB2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	3449427	CHEMBL1244821	Binding affinity to EPHB2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1900.0	CHEMBL3290	Homo sapiens	Kd	nM	1900.0
	3449654	CHEMBL1244821	Binding affinity to EPHB2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	3449926	CHEMBL1244821	Binding affinity to EPHB2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	3450330	CHEMBL1244821	Binding affinity to EPHB2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	3450986	CHEMBL1244821	Binding affinity to EPHB2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	uM	10.0
	3463222	CHEMBL1252410	Inhibition of EPHB2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	1.0	CHEMBL3290	Homo sapiens	INH	%	1.0
	3463441	CHEMBL1252410	Inhibition of EPHB2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	7.0	CHEMBL3290	Homo sapiens	INH	%	7.0
	3463985	CHEMBL1252410	Inhibition of EPHB2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	7.0	CHEMBL3290	Homo sapiens	INH	%	7.0
	3515516	CHEMBL1274779	Inhibition of EPHB2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271376	=	IC50	nM	82.0	CHEMBL3290	Homo sapiens	IC50	nM	82.0
	3515518	CHEMBL1274779	Inhibition of EPHB2	B	NC(=O)Cc1cccc(-n2nc(-c3cccs3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269839	>	IC50	nM	50000.0	CHEMBL3290	Homo sapiens	IC50	nM	50000.0
	5120368	CHEMBL1645954	Inhibition of human EphB2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	105.0	CHEMBL3290	Homo sapiens	INH	%	105.0
	5243698	CHEMBL1685661	Inhibition of EphB2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	99.0	CHEMBL3290	Homo sapiens	INH	%	99.0
	5243806	CHEMBL1685910	Inhibition of EphB2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	75.0	CHEMBL3290	Homo sapiens	INH	%	75.0
	5243919	CHEMBL1685661	Inhibition of EphB2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	87.0	CHEMBL3290	Homo sapiens	INH	%	87.0
	5244027	CHEMBL1685910	Inhibition of EphB2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	74.0	CHEMBL3290	Homo sapiens	INH	%	74.0
	5244900	CHEMBL1685661	Inhibition of EphB2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	88.0	CHEMBL3290	Homo sapiens	INH	%	88.0
	5245008	CHEMBL1685910	Inhibition of EphB2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	57.0	CHEMBL3290	Homo sapiens	INH	%	57.0
	5245159	CHEMBL1685661	Inhibition of EphB2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	107.0	CHEMBL3290	Homo sapiens	INH	%	107.0
	5245989	CHEMBL1685910	Inhibition of EphB2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	100.0	CHEMBL3290	Homo sapiens	INH	%	100.0
	6167016	CHEMBL1768902	Inhibition of EPHB2	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL3290	Homo sapiens	Ki	uM	1.0
	6171348	CHEMBL1769163	Inhibition of EPH-B2	B	CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1		CHEMBL1766529	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	nM	10000.0
	6196683	CHEMBL1776853	Inhibition of human EphB2	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)c(C#N)cc2F)n[nH]1		CHEMBL1774056	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	uM	10.0
	6210064	CHEMBL1781089	Inhibition of EPHB4 at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	5.1	CHEMBL3290	Homo sapiens	INH	%	5.1
	6212372	CHEMBL1786256	Inhibition of EphB2 expressed in Bac-to-Bac Baculovirus expression system using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	uM	10.0
	6304893	CHEMBL1816284	Inhibition of EPHB2	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	nM	10000.0
	6341053	CHEMBL1828222	Activity of EPHB2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3290	Homo sapiens	Activity	%	100.0
	7567522	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7567993	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7568461	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	19.0	CHEMBL3290	Homo sapiens	Kd	nM	19.0
	7568893	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7569036	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7569496	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7569968	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7570431	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7570858	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7571012	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7571469	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7571945	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7572408	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7572824	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1500.0	CHEMBL3290	Homo sapiens	Kd	nM	1500.0
	7572993	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7573450	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.39	CHEMBL3290	Homo sapiens	Kd	nM	0.39
	7573926	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3300.0	CHEMBL3290	Homo sapiens	Kd	nM	3300.0
	7574971	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7575432	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7575903	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7575926	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7576334	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7576945	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7577404	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3.9	CHEMBL3290	Homo sapiens	Kd	nM	3.9
	7577910	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7578315	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	3900.0	CHEMBL3290	Homo sapiens	Kd	nM	3900.0
	7578953	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7579327	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	440.0	CHEMBL3290	Homo sapiens	Kd	nM	440.0
	7579809	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7580278	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	560.0	CHEMBL3290	Homo sapiens	Kd	nM	560.0
	7580681	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	440.0	CHEMBL3290	Homo sapiens	Kd	nM	440.0
	7581699	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7582170	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7582634	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7583034	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	5600.0	CHEMBL3290	Homo sapiens	Kd	nM	5600.0
	7583215	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7583612	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7584057	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7584528	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7584990	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	880.0	CHEMBL3290	Homo sapiens	Kd	nM	880.0
	7585394	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7585545	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1400.0	CHEMBL3290	Homo sapiens	Kd	nM	1400.0
	7585953	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7586399	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7586870	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7587324	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7587506	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7587925	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7588378	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7588849	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7589300	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7589471	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7589895	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	6900.0	CHEMBL3290	Homo sapiens	Kd	nM	6900.0
	7590362	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7590836	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7591444	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7591866	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7592338	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7592822	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7593411	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	130.0	CHEMBL3290	Homo sapiens	Kd	nM	130.0
	7593846	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7594349	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7594801	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	8.4	CHEMBL3290	Homo sapiens	Kd	nM	8.4
	7595379	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7595823	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2700.0	CHEMBL3290	Homo sapiens	Kd	nM	2700.0
	7595855	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7596326	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	640.0	CHEMBL3290	Homo sapiens	Kd	nM	640.0
	7596773	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1900.0	CHEMBL3290	Homo sapiens	Kd	nM	1900.0
	7597351	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7597835	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7598305	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3290	Homo sapiens	Kd	nM	10000.0
	7598747	CHEMBL1908802	Binding constant for EPHB2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2100.0	CHEMBL3290	Homo sapiens	Kd	nM	2100.0
	7959747	CHEMBL1932848	Inhibition of EPHB2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	7200.0	CHEMBL3290	Homo sapiens	IC50	uM	7.2
	7959748	CHEMBL1932848	Inhibition of EPHB2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	160.0	CHEMBL3290	Homo sapiens	IC50	uM	0.16
	7969717	CHEMBL1931217	Inhibition of EPHB2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	4.0	CHEMBL3290	Homo sapiens	Activity	%	4.0
	7991942	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	44.0	CHEMBL3290	Homo sapiens	INH	%	44.0
	7991943	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	37.2	CHEMBL3290	Homo sapiens	INH	%	37.2
	7991944	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	48.6	CHEMBL3290	Homo sapiens	INH	%	48.6
	7991945	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	53.0	CHEMBL3290	Homo sapiens	INH	%	53.0
	7991946	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	49.2	CHEMBL3290	Homo sapiens	INH	%	49.2
	7991947	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	53.4	CHEMBL3290	Homo sapiens	INH	%	53.4
	7991948	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	35.8	CHEMBL3290	Homo sapiens	INH	%	35.8
	7991949	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	53.8	CHEMBL3290	Homo sapiens	INH	%	53.8
Not Determined	7991950	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
Not Determined	7991951	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
	7991952	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	89.2	CHEMBL3290	Homo sapiens	INH	%	89.2
Not Determined	7991953	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
Not Determined	7991954	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
Not Determined	7991955	CHEMBL1937683	Inhibition of EPH-B2 at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
	8061371	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.39	CHEMBL3290	Homo sapiens	Inhibition	%	-0.39
	8061548	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	9.74	CHEMBL3290	Homo sapiens	Inhibition	%	9.74
	8061655	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	12.93	CHEMBL3290	Homo sapiens	Inhibition	%	12.93
	8061879	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	44.11	CHEMBL3290	Homo sapiens	Inhibition	%	44.11
	8062070	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.99	CHEMBL3290	Homo sapiens	Inhibition	%	3.99
	8062410	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.59	CHEMBL3290	Homo sapiens	Inhibition	%	4.59
	8062572	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	8.11	CHEMBL3290	Homo sapiens	Inhibition	%	8.11
	8062894	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21	Outside typical range	CHEMBL185710	=	Inhibition	%	-11.63	CHEMBL3290	Homo sapiens	Inhibition	%	-11.63
	8063250	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	8.63	CHEMBL3290	Homo sapiens	Inhibition	%	8.63
	8063417	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.9	CHEMBL3290	Homo sapiens	Inhibition	%	3.9
	8063749	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.11	CHEMBL3290	Homo sapiens	Inhibition	%	6.11
	8063931	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	12.04	CHEMBL3290	Homo sapiens	Inhibition	%	12.04
	8064270	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.92	CHEMBL3290	Homo sapiens	Inhibition	%	3.92
	8064480	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.71	CHEMBL3290	Homo sapiens	Inhibition	%	0.71
	8064842	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.69	CHEMBL3290	Homo sapiens	Inhibition	%	-1.69
	8065008	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	10.0	CHEMBL3290	Homo sapiens	Inhibition	%	10.0
	8065348	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.48	CHEMBL3290	Homo sapiens	Inhibition	%	6.48
	8065523	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.11	CHEMBL3290	Homo sapiens	Inhibition	%	3.11
	8065747	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	18.07	CHEMBL3290	Homo sapiens	Inhibition	%	18.07
	8065862	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	5.07	CHEMBL3290	Homo sapiens	Inhibition	%	5.07
	8066072	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.82	CHEMBL3290	Homo sapiens	Inhibition	%	-1.82
	8066296	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-5.8	CHEMBL3290	Homo sapiens	Inhibition	%	-5.8
	8066432	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.55	CHEMBL3290	Homo sapiens	Inhibition	%	-1.55
	8066598	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.78	CHEMBL3290	Homo sapiens	Inhibition	%	1.78
	8066822	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.25	CHEMBL3290	Homo sapiens	Inhibition	%	5.25
	8066946	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	56.74	CHEMBL3290	Homo sapiens	Inhibition	%	56.74
	8067345	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	6.82	CHEMBL3290	Homo sapiens	Inhibition	%	6.82
	8067466	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	7.72	CHEMBL3290	Homo sapiens	Inhibition	%	7.72
	8067900	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-7.41	CHEMBL3290	Homo sapiens	Inhibition	%	-7.41
	8068035	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	4.13	CHEMBL3290	Homo sapiens	Inhibition	%	4.13
	8068423	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.84	CHEMBL3290	Homo sapiens	Inhibition	%	2.84
	8068548	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	80.38	CHEMBL3290	Homo sapiens	Inhibition	%	80.38
	8068772	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.69	CHEMBL3290	Homo sapiens	Inhibition	%	2.69
	8068946	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	14.65	CHEMBL3290	Homo sapiens	Inhibition	%	14.65
	8069071	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.2	CHEMBL3290	Homo sapiens	Inhibition	%	5.2
	8069295	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	17.74	CHEMBL3290	Homo sapiens	Inhibition	%	17.74
	8069366	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	40.16	CHEMBL3290	Homo sapiens	Inhibition	%	40.16
	8069590	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	11.83	CHEMBL3290	Homo sapiens	Inhibition	%	11.83
	8069751	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.63	CHEMBL3290	Homo sapiens	Inhibition	%	0.63
	8070101	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	5.96	CHEMBL3290	Homo sapiens	Inhibition	%	5.96
	8070273	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.58	CHEMBL3290	Homo sapiens	Inhibition	%	3.58
	8070622	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	7.84	CHEMBL3290	Homo sapiens	Inhibition	%	7.84
	8070920	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	57.9	CHEMBL3290	Homo sapiens	Inhibition	%	57.9
	8071077	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.48	CHEMBL3290	Homo sapiens	Inhibition	%	4.48
	8071427	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.55	CHEMBL3290	Homo sapiens	Inhibition	%	1.55
	8071600	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	6.51	CHEMBL3290	Homo sapiens	Inhibition	%	6.51
	8071824	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	7.31	CHEMBL3290	Homo sapiens	Inhibition	%	7.31
	8071949	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.4	CHEMBL3290	Homo sapiens	Inhibition	%	5.4
	8072263	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.54	CHEMBL3290	Homo sapiens	Inhibition	%	-0.54
	8072420	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.31	CHEMBL3290	Homo sapiens	Inhibition	%	1.31
	8072644	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	5.01	CHEMBL3290	Homo sapiens	Inhibition	%	5.01
	8072769	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	5.67	CHEMBL3290	Homo sapiens	Inhibition	%	5.67
	8073160	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.48	CHEMBL3290	Homo sapiens	Inhibition	%	5.48
	8073285	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	74.08	CHEMBL3290	Homo sapiens	Inhibition	%	74.08
	8073628	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-2.4	CHEMBL3290	Homo sapiens	Inhibition	%	-2.4
	8073861	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	8.15	CHEMBL3290	Homo sapiens	Inhibition	%	8.15
	8074237	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.12	CHEMBL3290	Homo sapiens	Inhibition	%	4.12
	8074367	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.66	CHEMBL3290	Homo sapiens	Inhibition	%	0.66
	8074748	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	6.12	CHEMBL3290	Homo sapiens	Inhibition	%	6.12
	8074875	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	83.72	CHEMBL3290	Homo sapiens	Inhibition	%	83.72
	8075099	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	5.06	CHEMBL3290	Homo sapiens	Inhibition	%	5.06
	8075210	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.87	CHEMBL3290	Homo sapiens	Inhibition	%	-1.87
	8075447	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-4.91	CHEMBL3290	Homo sapiens	Inhibition	%	-4.91
	8075812	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.83	CHEMBL3290	Homo sapiens	Inhibition	%	5.83
	8075954	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	3.29	CHEMBL3290	Homo sapiens	Inhibition	%	3.29
	8076178	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.25	CHEMBL3290	Homo sapiens	Inhibition	%	1.25
	8076326	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	6.53	CHEMBL3290	Homo sapiens	Inhibition	%	6.53
	8076684	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.09	CHEMBL3290	Homo sapiens	Inhibition	%	2.09
	8076786	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-4.85	CHEMBL3290	Homo sapiens	Inhibition	%	-4.85
	8077010	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-5.28	CHEMBL3290	Homo sapiens	Inhibition	%	-5.28
	8077033	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-4.07	CHEMBL3290	Homo sapiens	Inhibition	%	-4.07
	8077257	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-2.94	CHEMBL3290	Homo sapiens	Inhibition	%	-2.94
	8077385	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.04	CHEMBL3290	Homo sapiens	Inhibition	%	3.04
	8077760	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.95	CHEMBL3290	Homo sapiens	Inhibition	%	1.95
	8077903	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.87	CHEMBL3290	Homo sapiens	Inhibition	%	3.87
	8078266	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.09	CHEMBL3290	Homo sapiens	Inhibition	%	-3.09
	8078592	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-5.22	CHEMBL3290	Homo sapiens	Inhibition	%	-5.22
	8078842	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F	Outside typical range	CHEMBL1909349	=	Inhibition	%	-10.4	CHEMBL3290	Homo sapiens	Inhibition	%	-10.4
	8078958	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.86	CHEMBL3290	Homo sapiens	Inhibition	%	5.86
	8079182	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	8.63	CHEMBL3290	Homo sapiens	Inhibition	%	8.63
	8079340	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.2	CHEMBL3290	Homo sapiens	Inhibition	%	-0.2
	8079482	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	6.52	CHEMBL3290	Homo sapiens	Inhibition	%	6.52
	8079706	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.14	CHEMBL3290	Homo sapiens	Inhibition	%	4.14
	8079845	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.29	CHEMBL3290	Homo sapiens	Inhibition	%	-1.29
	8080174	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-8.09	CHEMBL3290	Homo sapiens	Inhibition	%	-8.09
	8080426	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-3.84	CHEMBL3290	Homo sapiens	Inhibition	%	-3.84
	8080765	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.16	CHEMBL3290	Homo sapiens	Inhibition	%	3.16
	8080929	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-2.42	CHEMBL3290	Homo sapiens	Inhibition	%	-2.42
	8081288	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.23	CHEMBL3290	Homo sapiens	Inhibition	%	-0.23
	8081432	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.06	CHEMBL3290	Homo sapiens	Inhibition	%	6.06
	8081759	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-3.19	CHEMBL3290	Homo sapiens	Inhibition	%	-3.19
	8082011	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-4.93	CHEMBL3290	Homo sapiens	Inhibition	%	-4.93
	8082348	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	6.18	CHEMBL3290	Homo sapiens	Inhibition	%	6.18
	8082521	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.07	CHEMBL3290	Homo sapiens	Inhibition	%	-3.07
	8082868	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	6.98	CHEMBL3290	Homo sapiens	Inhibition	%	6.98
	8083024	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	8.57	CHEMBL3290	Homo sapiens	Inhibition	%	8.57
	8083248	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.33	CHEMBL3290	Homo sapiens	Inhibition	%	5.33
	8083347	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-8.35	CHEMBL3290	Homo sapiens	Inhibition	%	-8.35
	8083601	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-7.08	CHEMBL3290	Homo sapiens	Inhibition	%	-7.08
	8083825	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-8.8	CHEMBL3290	Homo sapiens	Inhibition	%	-8.8
	8083935	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.98	CHEMBL3290	Homo sapiens	Inhibition	%	5.98
	8084120	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.74	CHEMBL3290	Homo sapiens	Inhibition	%	3.74
	8084344	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.06	CHEMBL3290	Homo sapiens	Inhibition	%	8.06
	8084462	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.05	CHEMBL3290	Homo sapiens	Inhibition	%	2.05
	8084847	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	13.29	CHEMBL3290	Homo sapiens	Inhibition	%	13.29
	8084945	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-4.01	CHEMBL3290	Homo sapiens	Inhibition	%	-4.01
	8085169	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1	Outside typical range	CHEMBL103080	=	Inhibition	%	-10.77	CHEMBL3290	Homo sapiens	Inhibition	%	-10.77
	8085425	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.14	CHEMBL3290	Homo sapiens	Inhibition	%	-3.14
	8085533	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	11.68	CHEMBL3290	Homo sapiens	Inhibition	%	11.68
	8085946	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	29.14	CHEMBL3290	Homo sapiens	Inhibition	%	29.14
	8086061	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.52	CHEMBL3290	Homo sapiens	Inhibition	%	2.52
	8086285	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.46	CHEMBL3290	Homo sapiens	Inhibition	%	0.46
	8086447	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.8	CHEMBL3290	Homo sapiens	Inhibition	%	2.8
	8086770	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.84	CHEMBL3290	Homo sapiens	Inhibition	%	-0.84
	8086981	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	10.32	CHEMBL3290	Homo sapiens	Inhibition	%	10.32
	8087139	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	12.87	CHEMBL3290	Homo sapiens	Inhibition	%	12.87
	8087363	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.82	CHEMBL3290	Homo sapiens	Inhibition	%	6.82
	8087477	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	43.57	CHEMBL3290	Homo sapiens	Inhibition	%	43.57
	8087839	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.33	CHEMBL3290	Homo sapiens	Inhibition	%	8.33
	8087981	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	10.11	CHEMBL3290	Homo sapiens	Inhibition	%	10.11
	8088205	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.73	CHEMBL3290	Homo sapiens	Inhibition	%	7.73
	8088353	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	6.68	CHEMBL3290	Homo sapiens	Inhibition	%	6.68
	8088705	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.76	CHEMBL3290	Homo sapiens	Inhibition	%	7.76
	8088798	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	6.72	CHEMBL3290	Homo sapiens	Inhibition	%	6.72
	8089022	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	10.13	CHEMBL3290	Homo sapiens	Inhibition	%	10.13
	8089150	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	5.31	CHEMBL3290	Homo sapiens	Inhibition	%	5.31
	8089522	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.72	CHEMBL3290	Homo sapiens	Inhibition	%	1.72
	8089642	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	9.58	CHEMBL3290	Homo sapiens	Inhibition	%	9.58
	8090046	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.83	CHEMBL3290	Homo sapiens	Inhibition	%	5.83
	8090211	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.75	CHEMBL3290	Homo sapiens	Inhibition	%	2.75
	8090602	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.43	CHEMBL3290	Homo sapiens	Inhibition	%	-0.43
	8090741	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	9.64	CHEMBL3290	Homo sapiens	Inhibition	%	9.64
	8091170	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	6.07	CHEMBL3290	Homo sapiens	Inhibition	%	6.07
	8091307	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	29.25	CHEMBL3290	Homo sapiens	Inhibition	%	29.25
	8091686	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	7.83	CHEMBL3290	Homo sapiens	Inhibition	%	7.83
	8091802	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.35	CHEMBL3290	Homo sapiens	Inhibition	%	7.35
	8092026	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	10.83	CHEMBL3290	Homo sapiens	Inhibition	%	10.83
	8092163	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.55	CHEMBL3290	Homo sapiens	Inhibition	%	5.55
	8092538	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	12.34	CHEMBL3290	Homo sapiens	Inhibition	%	12.34
	8092686	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	5.3	CHEMBL3290	Homo sapiens	Inhibition	%	5.3
	8093039	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	14.07	CHEMBL3290	Homo sapiens	Inhibition	%	14.07
	8093351	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	8.48	CHEMBL3290	Homo sapiens	Inhibition	%	8.48
	8093491	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	13.7	CHEMBL3290	Homo sapiens	Inhibition	%	13.7
	8093854	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.84	CHEMBL3290	Homo sapiens	Inhibition	%	5.84
	8093974	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.99	CHEMBL3290	Homo sapiens	Inhibition	%	4.99
	8094198	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	8.86	CHEMBL3290	Homo sapiens	Inhibition	%	8.86
	8094378	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-9.41	CHEMBL3290	Homo sapiens	Inhibition	%	-9.41
	8094553	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.39	CHEMBL3290	Homo sapiens	Inhibition	%	3.39
	8094777	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.59	CHEMBL3290	Homo sapiens	Inhibition	%	4.59
	8094933	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	7.29	CHEMBL3290	Homo sapiens	Inhibition	%	7.29
	8095073	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	10.89	CHEMBL3290	Homo sapiens	Inhibition	%	10.89
	8095297	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	54.79	CHEMBL3290	Homo sapiens	Inhibition	%	54.79
	8095500	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.66	CHEMBL3290	Homo sapiens	Inhibition	%	7.66
	8095641	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.59	CHEMBL3290	Homo sapiens	Inhibition	%	8.59
	8095865	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.88	CHEMBL3290	Homo sapiens	Inhibition	%	8.88
	8096013	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.85	CHEMBL3290	Homo sapiens	Inhibition	%	4.85
	8096354	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	11.89	CHEMBL3290	Homo sapiens	Inhibition	%	11.89
	8096493	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.52	CHEMBL3290	Homo sapiens	Inhibition	%	5.52
	8096873	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.92	CHEMBL3290	Homo sapiens	Inhibition	%	7.92
	8097020	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	5.23	CHEMBL3290	Homo sapiens	Inhibition	%	5.23
	8097244	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.33	CHEMBL3290	Homo sapiens	Inhibition	%	2.33
	8097331	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	12.03	CHEMBL3290	Homo sapiens	Inhibition	%	12.03
	8097551	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	28.19	CHEMBL3290	Homo sapiens	Inhibition	%	28.19
	8097701	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.0	CHEMBL3290	Homo sapiens	Inhibition	%	5.0
	8097925	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	12.1	CHEMBL3290	Homo sapiens	Inhibition	%	12.1
	8098058	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.25	CHEMBL3290	Homo sapiens	Inhibition	%	0.25
	8098402	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.9	CHEMBL3290	Homo sapiens	Inhibition	%	-2.9
	8098582	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.46	CHEMBL3290	Homo sapiens	Inhibition	%	3.46
	8098991	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.15	CHEMBL3290	Homo sapiens	Inhibition	%	1.15
	8099135	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.86	CHEMBL3290	Homo sapiens	Inhibition	%	3.86
	8099501	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.43	CHEMBL3290	Homo sapiens	Inhibition	%	5.43
	8099695	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	8.8	CHEMBL3290	Homo sapiens	Inhibition	%	8.8
	8100066	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.77	CHEMBL3290	Homo sapiens	Inhibition	%	6.77
	8100212	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.52	CHEMBL3290	Homo sapiens	Inhibition	%	7.52
	8100552	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	10.62	CHEMBL3290	Homo sapiens	Inhibition	%	10.62
	8100692	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	6.04	CHEMBL3290	Homo sapiens	Inhibition	%	6.04
	8100916	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	5.17	CHEMBL3290	Homo sapiens	Inhibition	%	5.17
	8101076	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.39	CHEMBL3290	Homo sapiens	Inhibition	%	5.39
	8101442	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.44	CHEMBL3290	Homo sapiens	Inhibition	%	-1.44
	8101627	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.75	CHEMBL3290	Homo sapiens	Inhibition	%	6.75
	8101880	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	10.3	CHEMBL3290	Homo sapiens	Inhibition	%	10.3
	8102259	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	30.42	CHEMBL3290	Homo sapiens	Inhibition	%	30.42
	8102390	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.77	CHEMBL3290	Homo sapiens	Inhibition	%	3.77
	8102734	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.89	CHEMBL3290	Homo sapiens	Inhibition	%	0.89
	8102912	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1	Outside typical range	CHEMBL215993	=	Inhibition	%	-10.85	CHEMBL3290	Homo sapiens	Inhibition	%	-10.85
	8103136	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.06	CHEMBL3290	Homo sapiens	Inhibition	%	1.06
	8103332	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.04	CHEMBL3290	Homo sapiens	Inhibition	%	0.04
	8103470	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	7.45	CHEMBL3290	Homo sapiens	Inhibition	%	7.45
	8103694	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	3.44	CHEMBL3290	Homo sapiens	Inhibition	%	3.44
	8103844	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	9.0	CHEMBL3290	Homo sapiens	Inhibition	%	9.0
	8104029	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	24.5	CHEMBL3290	Homo sapiens	Inhibition	%	24.5
	8104401	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.45	CHEMBL3290	Homo sapiens	Inhibition	%	9.45
	8104547	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	6.73	CHEMBL3290	Homo sapiens	Inhibition	%	6.73
	8104771	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	7.61	CHEMBL3290	Homo sapiens	Inhibition	%	7.61
	8104885	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	11.04	CHEMBL3290	Homo sapiens	Inhibition	%	11.04
	8105249	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	5.34	CHEMBL3290	Homo sapiens	Inhibition	%	5.34
	8105415	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.22	CHEMBL3290	Homo sapiens	Inhibition	%	8.22
	8105777	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	5.83	CHEMBL3290	Homo sapiens	Inhibition	%	5.83
	8106057	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	6.52	CHEMBL3290	Homo sapiens	Inhibition	%	6.52
	8106222	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	25.94	CHEMBL3290	Homo sapiens	Inhibition	%	25.94
	8106446	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	8.88	CHEMBL3290	Homo sapiens	Inhibition	%	8.88
	8106602	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	77.81	CHEMBL3290	Homo sapiens	Inhibition	%	77.81
	8106731	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	5.55	CHEMBL3290	Homo sapiens	Inhibition	%	5.55
	8106955	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	15.14	CHEMBL3290	Homo sapiens	Inhibition	%	15.14
	8107076	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-2.33	CHEMBL3290	Homo sapiens	Inhibition	%	-2.33
	8107472	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-4.03	CHEMBL3290	Homo sapiens	Inhibition	%	-4.03
	8107673	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.23	CHEMBL3290	Homo sapiens	Inhibition	%	0.23
	8108032	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	18.11	CHEMBL3290	Homo sapiens	Inhibition	%	18.11
	8108190	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.44	CHEMBL3290	Homo sapiens	Inhibition	%	5.44
	8108365	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	36.92	CHEMBL3290	Homo sapiens	Inhibition	%	36.92
	8108589	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	68.0	CHEMBL3290	Homo sapiens	Inhibition	%	68.0
	8108736	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.82	CHEMBL3290	Homo sapiens	Inhibition	%	9.82
	8109102	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	8.0	CHEMBL3290	Homo sapiens	Inhibition	%	8.0
	8109216	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	10.27	CHEMBL3290	Homo sapiens	Inhibition	%	10.27
	8109440	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.48	CHEMBL3290	Homo sapiens	Inhibition	%	5.48
	8109570	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.26	CHEMBL3290	Homo sapiens	Inhibition	%	3.26
	8109741	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	7.8	CHEMBL3290	Homo sapiens	Inhibition	%	7.8
	8109965	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	7.99	CHEMBL3290	Homo sapiens	Inhibition	%	7.99
	8110097	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.98	CHEMBL3290	Homo sapiens	Inhibition	%	8.98
	8110376	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	10.69	CHEMBL3290	Homo sapiens	Inhibition	%	10.69
	8110766	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	19.68	CHEMBL3290	Homo sapiens	Inhibition	%	19.68
	8110924	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-6.0	CHEMBL3290	Homo sapiens	Inhibition	%	-6.0
	8111271	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	44.49	CHEMBL3290	Homo sapiens	Inhibition	%	44.49
	8111398	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-2.78	CHEMBL3290	Homo sapiens	Inhibition	%	-2.78
	8111622	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-7.23	CHEMBL3290	Homo sapiens	Inhibition	%	-7.23
	8111788	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.29	CHEMBL3290	Homo sapiens	Inhibition	%	4.29
	8111993	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.55	CHEMBL3290	Homo sapiens	Inhibition	%	0.55
	8112354	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.52	CHEMBL3290	Homo sapiens	Inhibition	%	2.52
	8112522	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	13.99	CHEMBL3290	Homo sapiens	Inhibition	%	13.99
	8112918	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.8	CHEMBL3290	Homo sapiens	Inhibition	%	4.8
	8113070	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.25	CHEMBL3290	Homo sapiens	Inhibition	%	8.25
	8113430	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	6.76	CHEMBL3290	Homo sapiens	Inhibition	%	6.76
	8113778	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	7.01	CHEMBL3290	Homo sapiens	Inhibition	%	7.01
	8113894	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.48	CHEMBL3290	Homo sapiens	Inhibition	%	-3.48
	8114294	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	7.05	CHEMBL3290	Homo sapiens	Inhibition	%	7.05
	8114426	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	11.46	CHEMBL3290	Homo sapiens	Inhibition	%	11.46
	8114702	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	6.79	CHEMBL3290	Homo sapiens	Inhibition	%	6.79
	8115092	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	55.42	CHEMBL3290	Homo sapiens	Inhibition	%	55.42
	8115257	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-5.25	CHEMBL3290	Homo sapiens	Inhibition	%	-5.25
	8115601	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	62.99	CHEMBL3290	Homo sapiens	Inhibition	%	62.99
	8115958	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-3.01	CHEMBL3290	Homo sapiens	Inhibition	%	-3.01
	8116117	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-4.35	CHEMBL3290	Homo sapiens	Inhibition	%	-4.35
	8116320	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.78	CHEMBL3290	Homo sapiens	Inhibition	%	2.78
	8116544	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-2.87	CHEMBL3290	Homo sapiens	Inhibition	%	-2.87
	8116678	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.31	CHEMBL3290	Homo sapiens	Inhibition	%	3.31
	8116850	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	67.84	CHEMBL3290	Homo sapiens	Inhibition	%	67.84
	8117074	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	88.69	CHEMBL3290	Homo sapiens	Inhibition	%	88.69
	8117245	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	7.96	CHEMBL3290	Homo sapiens	Inhibition	%	7.96
	8117403	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.92	CHEMBL3290	Homo sapiens	Inhibition	%	8.92
	8117627	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.26	CHEMBL3290	Homo sapiens	Inhibition	%	8.26
	8117757	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	5.36	CHEMBL3290	Homo sapiens	Inhibition	%	5.36
	8118119	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.59	CHEMBL3290	Homo sapiens	Inhibition	%	6.59
	8118235	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.73	CHEMBL3290	Homo sapiens	Inhibition	%	-1.73
	8118459	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.67	CHEMBL3290	Homo sapiens	Inhibition	%	8.67
	8118631	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.28	CHEMBL3290	Homo sapiens	Inhibition	%	6.28
	8118767	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	9.21	CHEMBL3290	Homo sapiens	Inhibition	%	9.21
	8118991	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	8.15	CHEMBL3290	Homo sapiens	Inhibition	%	8.15
	8119038	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	7.74	CHEMBL3290	Homo sapiens	Inhibition	%	7.74
	8119262	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.98	CHEMBL3290	Homo sapiens	Inhibition	%	4.98
	8119421	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	80.19	CHEMBL3290	Homo sapiens	Inhibition	%	80.19
	8119588	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.46	CHEMBL3290	Homo sapiens	Inhibition	%	-1.46
	8119812	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.49	CHEMBL3290	Homo sapiens	Inhibition	%	4.49
	8119931	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	13.73	CHEMBL3290	Homo sapiens	Inhibition	%	13.73
	8120294	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-7.93	CHEMBL3290	Homo sapiens	Inhibition	%	-7.93
	8120454	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	7.99	CHEMBL3290	Homo sapiens	Inhibition	%	7.99
	8120678	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-3.66	CHEMBL3290	Homo sapiens	Inhibition	%	-3.66
	8120879	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.11	CHEMBL3290	Homo sapiens	Inhibition	%	4.11
	8121007	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.18	CHEMBL3290	Homo sapiens	Inhibition	%	0.18
	8121403	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	7.69	CHEMBL3290	Homo sapiens	Inhibition	%	7.69
	8121570	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.47	CHEMBL3290	Homo sapiens	Inhibition	%	4.47
	8121957	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.64	CHEMBL3290	Homo sapiens	Inhibition	%	5.64
	8122078	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	11.53	CHEMBL3290	Homo sapiens	Inhibition	%	11.53
	8122302	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	55.66	CHEMBL3290	Homo sapiens	Inhibition	%	55.66
	8122440	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	8.76	CHEMBL3290	Homo sapiens	Inhibition	%	8.76
	8122784	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.13	CHEMBL3290	Homo sapiens	Inhibition	%	8.13
	8122951	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	8.19	CHEMBL3290	Homo sapiens	Inhibition	%	8.19
	8123317	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	14.91	CHEMBL3290	Homo sapiens	Inhibition	%	14.91
	8123595	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	8.75	CHEMBL3290	Homo sapiens	Inhibition	%	8.75
	8123745	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	9.57	CHEMBL3290	Homo sapiens	Inhibition	%	9.57
	8124136	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.42	CHEMBL3290	Homo sapiens	Inhibition	%	2.42
	8124255	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	22.53	CHEMBL3290	Homo sapiens	Inhibition	%	22.53
	8124479	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	9.43	CHEMBL3290	Homo sapiens	Inhibition	%	9.43
	8124618	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.37	CHEMBL3290	Homo sapiens	Inhibition	%	1.37
	8125007	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.97	CHEMBL3290	Homo sapiens	Inhibition	%	1.97
	8125208	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.76	CHEMBL3290	Homo sapiens	Inhibition	%	4.76
	8125338	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.71	CHEMBL3290	Homo sapiens	Inhibition	%	3.71
	8125562	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.05	CHEMBL3290	Homo sapiens	Inhibition	%	0.05
	8125730	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	6.03	CHEMBL3290	Homo sapiens	Inhibition	%	6.03
	8125894	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.15	CHEMBL3290	Homo sapiens	Inhibition	%	5.15
	8126118	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.41	CHEMBL3290	Homo sapiens	Inhibition	%	0.41
	8126282	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	10.93	CHEMBL3290	Homo sapiens	Inhibition	%	10.93
	8126621	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	81.55	CHEMBL3290	Homo sapiens	Inhibition	%	81.55
	8126757	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	9.09	CHEMBL3290	Homo sapiens	Inhibition	%	9.09
	8127103	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.52	CHEMBL3290	Homo sapiens	Inhibition	%	7.52
	8127270	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	15.42	CHEMBL3290	Homo sapiens	Inhibition	%	15.42
	8127494	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	18.46	CHEMBL3290	Homo sapiens	Inhibition	%	18.46
	8127636	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	17.27	CHEMBL3290	Homo sapiens	Inhibition	%	17.27
	8127924	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.87	CHEMBL3290	Homo sapiens	Inhibition	%	4.87
	8128076	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	18.22	CHEMBL3290	Homo sapiens	Inhibition	%	18.22
	8128300	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	9.34	CHEMBL3290	Homo sapiens	Inhibition	%	9.34
	8128467	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	16.21	CHEMBL3290	Homo sapiens	Inhibition	%	16.21
	8128810	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	35.96	CHEMBL3290	Homo sapiens	Inhibition	%	35.96
	8128947	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1	Outside typical range	CHEMBL352222	=	Inhibition	%	-10.44	CHEMBL3290	Homo sapiens	Inhibition	%	-10.44
	8129342	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-5.39	CHEMBL3290	Homo sapiens	Inhibition	%	-5.39
	8129531	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	9.06	CHEMBL3290	Homo sapiens	Inhibition	%	9.06
	8129894	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.72	CHEMBL3290	Homo sapiens	Inhibition	%	3.72
	8130055	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	5.3	CHEMBL3290	Homo sapiens	Inhibition	%	5.3
	8130451	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.53	CHEMBL3290	Homo sapiens	Inhibition	%	0.53
	8130611	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	8.25	CHEMBL3290	Homo sapiens	Inhibition	%	8.25
	8130951	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	6.94	CHEMBL3290	Homo sapiens	Inhibition	%	6.94
	8131090	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	18.14	CHEMBL3290	Homo sapiens	Inhibition	%	18.14
	8131314	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	9.03	CHEMBL3290	Homo sapiens	Inhibition	%	9.03
	8131434	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.3	CHEMBL3290	Homo sapiens	Inhibition	%	7.3
	8131825	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	45.9	CHEMBL3290	Homo sapiens	Inhibition	%	45.9
	8131966	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	74.13	CHEMBL3290	Homo sapiens	Inhibition	%	74.13
	8132252	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	8.52	CHEMBL3290	Homo sapiens	Inhibition	%	8.52
	8132623	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	22.46	CHEMBL3290	Homo sapiens	Inhibition	%	22.46
	8132791	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.8	CHEMBL3290	Homo sapiens	Inhibition	%	-0.8
	8133136	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.93	CHEMBL3290	Homo sapiens	Inhibition	%	7.93
	8133274	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.02	CHEMBL3290	Homo sapiens	Inhibition	%	0.02
	8133498	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-4.82	CHEMBL3290	Homo sapiens	Inhibition	%	-4.82
	8133670	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	6.81	CHEMBL3290	Homo sapiens	Inhibition	%	6.81
	8133850	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	8.44	CHEMBL3290	Homo sapiens	Inhibition	%	8.44
	8134074	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	34.29	CHEMBL3290	Homo sapiens	Inhibition	%	34.29
	8134222	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-3.46	CHEMBL3290	Homo sapiens	Inhibition	%	-3.46
	8134382	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.55	CHEMBL3290	Homo sapiens	Inhibition	%	4.55
	8134606	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.46	CHEMBL3290	Homo sapiens	Inhibition	%	2.46
	8134790	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-6.42	CHEMBL3290	Homo sapiens	Inhibition	%	-6.42
	8134950	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	27.23	CHEMBL3290	Homo sapiens	Inhibition	%	27.23
	8135174	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.94	CHEMBL3290	Homo sapiens	Inhibition	%	5.94
	8135289	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	8.79	CHEMBL3290	Homo sapiens	Inhibition	%	8.79
	8135654	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.2	CHEMBL3290	Homo sapiens	Inhibition	%	7.2
	8135775	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	7.0	CHEMBL3290	Homo sapiens	Inhibition	%	7.0
	8135999	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.49	CHEMBL3290	Homo sapiens	Inhibition	%	5.49
	8136167	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	8.19	CHEMBL3290	Homo sapiens	Inhibition	%	8.19
	8136311	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	78.22	CHEMBL3290	Homo sapiens	Inhibition	%	78.22
	8136535	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	10.62	CHEMBL3290	Homo sapiens	Inhibition	%	10.62
	8136601	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.81	CHEMBL3290	Homo sapiens	Inhibition	%	2.81
	8136825	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.5	CHEMBL3290	Homo sapiens	Inhibition	%	4.5
	8136960	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.7	CHEMBL3290	Homo sapiens	Inhibition	%	7.7
	8137123	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	8.47	CHEMBL3290	Homo sapiens	Inhibition	%	8.47
	8137347	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-1.54	CHEMBL3290	Homo sapiens	Inhibition	%	-1.54
	8137467	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	9.79	CHEMBL3290	Homo sapiens	Inhibition	%	9.79
	8137839	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.83	CHEMBL3290	Homo sapiens	Inhibition	%	3.83
	8138005	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-7.95	CHEMBL3290	Homo sapiens	Inhibition	%	-7.95
	8138408	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.86	CHEMBL3290	Homo sapiens	Inhibition	%	0.86
	8138556	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.07	CHEMBL3290	Homo sapiens	Inhibition	%	4.07
	8138938	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.88	CHEMBL3290	Homo sapiens	Inhibition	%	5.88
	8139123	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.55	CHEMBL3290	Homo sapiens	Inhibition	%	0.55
	8139506	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	12.83	CHEMBL3290	Homo sapiens	Inhibition	%	12.83
	8139620	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.71	CHEMBL3290	Homo sapiens	Inhibition	%	7.71
	8139985	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	9.52	CHEMBL3290	Homo sapiens	Inhibition	%	9.52
	8140332	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.65	CHEMBL3290	Homo sapiens	Inhibition	%	8.65
	8140491	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.8	CHEMBL3290	Homo sapiens	Inhibition	%	5.8
	8140858	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	16.54	CHEMBL3290	Homo sapiens	Inhibition	%	16.54
	8141160	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.81	CHEMBL3290	Homo sapiens	Inhibition	%	2.81
	8141290	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	12.49	CHEMBL3290	Homo sapiens	Inhibition	%	12.49
	8141674	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	9.31	CHEMBL3290	Homo sapiens	Inhibition	%	9.31
	8141793	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	23.17	CHEMBL3290	Homo sapiens	Inhibition	%	23.17
	8142017	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	65.93	CHEMBL3290	Homo sapiens	Inhibition	%	65.93
	8142178	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.72	CHEMBL3290	Homo sapiens	Inhibition	%	1.72
	8142346	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.34	CHEMBL3290	Homo sapiens	Inhibition	%	-0.34
	8142570	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-9.54	CHEMBL3290	Homo sapiens	Inhibition	%	-9.54
	8142746	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.37	CHEMBL3290	Homo sapiens	Inhibition	%	6.37
	8142895	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-9.67	CHEMBL3290	Homo sapiens	Inhibition	%	-9.67
	8143119	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.35	CHEMBL3290	Homo sapiens	Inhibition	%	0.35
	8143274	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.34	CHEMBL3290	Homo sapiens	Inhibition	%	1.34
	8143461	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.47	CHEMBL3290	Homo sapiens	Inhibition	%	5.47
	8143844	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	17.57	CHEMBL3290	Homo sapiens	Inhibition	%	17.57
	8143958	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.29	CHEMBL3290	Homo sapiens	Inhibition	%	5.29
	8144182	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	7.88	CHEMBL3290	Homo sapiens	Inhibition	%	7.88
	8144321	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.63	CHEMBL3290	Homo sapiens	Inhibition	%	7.63
	8144675	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.11	CHEMBL3290	Homo sapiens	Inhibition	%	4.11
	8144828	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.73	CHEMBL3290	Homo sapiens	Inhibition	%	2.73
	8145189	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	14.69	CHEMBL3290	Homo sapiens	Inhibition	%	14.69
	8145502	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	9.31	CHEMBL3290	Homo sapiens	Inhibition	%	9.31
	8145626	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.87	CHEMBL3290	Homo sapiens	Inhibition	%	6.87
	8145850	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	12.68	CHEMBL3290	Homo sapiens	Inhibition	%	12.68
	8146011	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.12	CHEMBL3290	Homo sapiens	Inhibition	%	4.12
	8146355	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	43.4	CHEMBL3290	Homo sapiens	Inhibition	%	43.4
	8146515	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	Inhibition	%	35.0
	8146906	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.46	CHEMBL3290	Homo sapiens	Inhibition	%	-1.46
	8147075	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.98	CHEMBL3290	Homo sapiens	Inhibition	%	-0.98
	8147441	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.58	CHEMBL3290	Homo sapiens	Inhibition	%	4.58
	8147594	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	6.65	CHEMBL3290	Homo sapiens	Inhibition	%	6.65
	8147781	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.84	CHEMBL3290	Homo sapiens	Inhibition	%	6.84
	8148005	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.3	CHEMBL3290	Homo sapiens	Inhibition	%	6.3
	8148163	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	51.73	CHEMBL3290	Homo sapiens	Inhibition	%	51.73
	8148501	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	6.61	CHEMBL3290	Homo sapiens	Inhibition	%	6.61
	8148640	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.19	CHEMBL3290	Homo sapiens	Inhibition	%	8.19
	8148864	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	9.58	CHEMBL3290	Homo sapiens	Inhibition	%	9.58
	8149002	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.08	CHEMBL3290	Homo sapiens	Inhibition	%	8.08
	8149161	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.41	CHEMBL3290	Homo sapiens	Inhibition	%	5.41
	8149385	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	6.06	CHEMBL3290	Homo sapiens	Inhibition	%	6.06
	8149519	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	12.99	CHEMBL3290	Homo sapiens	Inhibition	%	12.99
	8149841	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	12.41	CHEMBL3290	Homo sapiens	Inhibition	%	12.41
	8150190	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	36.07	CHEMBL3290	Homo sapiens	Inhibition	%	36.07
	8150350	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	27.33	CHEMBL3290	Homo sapiens	Inhibition	%	27.33
	8150694	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	79.89	CHEMBL3290	Homo sapiens	Inhibition	%	79.89
	8150859	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-6.85	CHEMBL3290	Homo sapiens	Inhibition	%	-6.85
	8151246	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1	Outside typical range	CHEMBL495902	=	Inhibition	%	-15.52	CHEMBL3290	Homo sapiens	Inhibition	%	-15.52
	8151423	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	8.66	CHEMBL3290	Homo sapiens	Inhibition	%	8.66
	8151785	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	6.85	CHEMBL3290	Homo sapiens	Inhibition	%	6.85
	8151939	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.91	CHEMBL3290	Homo sapiens	Inhibition	%	2.91
	8152163	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	6.69	CHEMBL3290	Homo sapiens	Inhibition	%	6.69
	8152351	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.02	CHEMBL3290	Homo sapiens	Inhibition	%	7.02
	8152509	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.58	CHEMBL3290	Homo sapiens	Inhibition	%	7.58
	8152847	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	16.41	CHEMBL3290	Homo sapiens	Inhibition	%	16.41
	8153210	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.13	CHEMBL3290	Homo sapiens	Inhibition	%	5.13
	8153347	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.72	CHEMBL3290	Homo sapiens	Inhibition	%	4.72
	8153728	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.79	CHEMBL3290	Homo sapiens	Inhibition	%	4.79
	8153861	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	12.14	CHEMBL3290	Homo sapiens	Inhibition	%	12.14
	8154085	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.7	CHEMBL3290	Homo sapiens	Inhibition	%	7.7
	8154182	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	52.78	CHEMBL3290	Homo sapiens	Inhibition	%	52.78
	8154532	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	78.35	CHEMBL3290	Homo sapiens	Inhibition	%	78.35
	8154691	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.54	CHEMBL3290	Homo sapiens	Inhibition	%	3.54
	8154915	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	6.47	CHEMBL3290	Homo sapiens	Inhibition	%	6.47
	8155035	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	4.28	CHEMBL3290	Homo sapiens	Inhibition	%	4.28
	8155211	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	5.1	CHEMBL3290	Homo sapiens	Inhibition	%	5.1
	8155435	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-9.27	CHEMBL3290	Homo sapiens	Inhibition	%	-9.27
	8155596	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-4.6	CHEMBL3290	Homo sapiens	Inhibition	%	-4.6
	8155774	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	-1.23	CHEMBL3290	Homo sapiens	Inhibition	%	-1.23
	8155998	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.11	CHEMBL3290	Homo sapiens	Inhibition	%	5.11
	8156136	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.74	CHEMBL3290	Homo sapiens	Inhibition	%	7.74
	8156348	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	7.89	CHEMBL3290	Homo sapiens	Inhibition	%	7.89
	8156572	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	9.13	CHEMBL3290	Homo sapiens	Inhibition	%	9.13
	8156722	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	21.79	CHEMBL3290	Homo sapiens	Inhibition	%	21.79
	8156865	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.54	CHEMBL3290	Homo sapiens	Inhibition	%	5.54
	8157089	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.75	CHEMBL3290	Homo sapiens	Inhibition	%	7.75
	8157209	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.5	CHEMBL3290	Homo sapiens	Inhibition	%	5.5
	8157574	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	17.14	CHEMBL3290	Homo sapiens	Inhibition	%	17.14
	8157704	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	61.76	CHEMBL3290	Homo sapiens	Inhibition	%	61.76
	8157928	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.38	CHEMBL3290	Homo sapiens	Inhibition	%	5.38
	8158089	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	8.3	CHEMBL3290	Homo sapiens	Inhibition	%	8.3
	8158339	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	12.46	CHEMBL3290	Homo sapiens	Inhibition	%	12.46
	8158721	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.65	CHEMBL3290	Homo sapiens	Inhibition	%	6.65
	8158890	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	6.32	CHEMBL3290	Homo sapiens	Inhibition	%	6.32
	8159249	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.71	CHEMBL3290	Homo sapiens	Inhibition	%	7.71
	8159369	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.01	CHEMBL3290	Homo sapiens	Inhibition	%	6.01
	8159593	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.66	CHEMBL3290	Homo sapiens	Inhibition	%	1.66
	8159724	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	12.45	CHEMBL3290	Homo sapiens	Inhibition	%	12.45
	8160089	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.77	CHEMBL3290	Homo sapiens	Inhibition	%	3.77
	8160226	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.79	CHEMBL3290	Homo sapiens	Inhibition	%	8.79
	8160600	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	7.37	CHEMBL3290	Homo sapiens	Inhibition	%	7.37
	8160894	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	36.62	CHEMBL3290	Homo sapiens	Inhibition	%	36.62
	8161044	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	6.47	CHEMBL3290	Homo sapiens	Inhibition	%	6.47
	8161411	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	12.05	CHEMBL3290	Homo sapiens	Inhibition	%	12.05
	8161536	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.69	CHEMBL3290	Homo sapiens	Inhibition	%	3.69
	8161760	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.61	CHEMBL3290	Homo sapiens	Inhibition	%	5.61
	8161898	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	57.13	CHEMBL3290	Homo sapiens	Inhibition	%	57.13
	8162252	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	12.15	CHEMBL3290	Homo sapiens	Inhibition	%	12.15
	8162412	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	9.54	CHEMBL3290	Homo sapiens	Inhibition	%	9.54
	8162665	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.01	CHEMBL3290	Homo sapiens	Inhibition	%	5.01
	8163037	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.62	CHEMBL3290	Homo sapiens	Inhibition	%	4.62
	8163206	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	8.75	CHEMBL3290	Homo sapiens	Inhibition	%	8.75
	8163564	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.81	CHEMBL3290	Homo sapiens	Inhibition	%	6.81
	8163911	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.7	CHEMBL3290	Homo sapiens	Inhibition	%	6.7
	8164045	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.14	CHEMBL3290	Homo sapiens	Inhibition	%	8.14
	8164409	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.78	CHEMBL3290	Homo sapiens	Inhibition	%	0.78
	8164564	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	12.93	CHEMBL3290	Homo sapiens	Inhibition	%	12.93
	8164932	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	35.91	CHEMBL3290	Homo sapiens	Inhibition	%	35.91
	8165226	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.66	CHEMBL3290	Homo sapiens	Inhibition	%	8.66
	8165367	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	17.06	CHEMBL3290	Homo sapiens	Inhibition	%	17.06
	8165591	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	6.07	CHEMBL3290	Homo sapiens	Inhibition	%	6.07
	8165734	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	29.43	CHEMBL3290	Homo sapiens	Inhibition	%	29.43
	8166084	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	7.6	CHEMBL3290	Homo sapiens	Inhibition	%	7.6
	8166222	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.43	CHEMBL3290	Homo sapiens	Inhibition	%	5.43
	8166576	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	8.8	CHEMBL3290	Homo sapiens	Inhibition	%	8.8
	8166901	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	65.53	CHEMBL3290	Homo sapiens	Inhibition	%	65.53
	8166989	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.1	CHEMBL3290	Homo sapiens	Inhibition	%	6.1
	8167213	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.7	CHEMBL3290	Homo sapiens	Inhibition	%	5.7
	8167354	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	26.07	CHEMBL3290	Homo sapiens	Inhibition	%	26.07
	8167518	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.23	CHEMBL3290	Homo sapiens	Inhibition	%	5.23
	8167742	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.91	CHEMBL3290	Homo sapiens	Inhibition	%	6.91
	8167875	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.78	CHEMBL3290	Homo sapiens	Inhibition	%	7.78
	8168223	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.76	CHEMBL3290	Homo sapiens	Inhibition	%	2.76
	8168364	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	15.82	CHEMBL3290	Homo sapiens	Inhibition	%	15.82
	8168588	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	9.21	CHEMBL3290	Homo sapiens	Inhibition	%	9.21
	8168724	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	4.85	CHEMBL3290	Homo sapiens	Inhibition	%	4.85
	8168888	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	15.05	CHEMBL3290	Homo sapiens	Inhibition	%	15.05
	8169112	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	46.23	CHEMBL3290	Homo sapiens	Inhibition	%	46.23
	8169254	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	9.15	CHEMBL3290	Homo sapiens	Inhibition	%	9.15
	8169558	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	9.33	CHEMBL3290	Homo sapiens	Inhibition	%	9.33
	8169916	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	8.53	CHEMBL3290	Homo sapiens	Inhibition	%	8.53
	8170061	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	22.03	CHEMBL3290	Homo sapiens	Inhibition	%	22.03
	8170410	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.03	CHEMBL3290	Homo sapiens	Inhibition	%	7.03
	8170550	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	10.56	CHEMBL3290	Homo sapiens	Inhibition	%	10.56
	8170774	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.63	CHEMBL3290	Homo sapiens	Inhibition	%	1.63
	8170909	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	26.05	CHEMBL3290	Homo sapiens	Inhibition	%	26.05
	8171106	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	58.78	CHEMBL3290	Homo sapiens	Inhibition	%	58.78
	8171330	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	19.31	CHEMBL3290	Homo sapiens	Inhibition	%	19.31
	8171547	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.97	CHEMBL3290	Homo sapiens	Inhibition	%	6.97
	8171688	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.01	CHEMBL3290	Homo sapiens	Inhibition	%	6.01
	8172065	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.17	CHEMBL3290	Homo sapiens	Inhibition	%	3.17
	8172197	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	12.55	CHEMBL3290	Homo sapiens	Inhibition	%	12.55
	8172421	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	15.94	CHEMBL3290	Homo sapiens	Inhibition	%	15.94
	8172549	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	5.02	CHEMBL3290	Homo sapiens	Inhibition	%	5.02
	8172915	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	40.31	CHEMBL3290	Homo sapiens	Inhibition	%	40.31
	8173051	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.84	CHEMBL3290	Homo sapiens	Inhibition	%	-1.84
	8173440	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	8.96	CHEMBL3290	Homo sapiens	Inhibition	%	8.96
	8173581	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	11.63	CHEMBL3290	Homo sapiens	Inhibition	%	11.63
	8173805	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	7.83	CHEMBL3290	Homo sapiens	Inhibition	%	7.83
	8173892	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	11.43	CHEMBL3290	Homo sapiens	Inhibition	%	11.43
	8174248	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	15.28	CHEMBL3290	Homo sapiens	Inhibition	%	15.28
	8174396	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	68.18	CHEMBL3290	Homo sapiens	Inhibition	%	68.18
	8174620	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	6.78	CHEMBL3290	Homo sapiens	Inhibition	%	6.78
	8174742	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.1	CHEMBL3290	Homo sapiens	Inhibition	%	5.1
	8175109	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	7.37	CHEMBL3290	Homo sapiens	Inhibition	%	7.37
	8175245	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	7.64	CHEMBL3290	Homo sapiens	Inhibition	%	7.64
	8175501	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.5	CHEMBL3290	Homo sapiens	Inhibition	%	3.5
	8175725	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	8.52	CHEMBL3290	Homo sapiens	Inhibition	%	8.52
	8175888	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	7.61	CHEMBL3290	Homo sapiens	Inhibition	%	7.61
	8176041	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	9.01	CHEMBL3290	Homo sapiens	Inhibition	%	9.01
	8176265	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.63	CHEMBL3290	Homo sapiens	Inhibition	%	6.63
	8176414	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	4.03	CHEMBL3290	Homo sapiens	Inhibition	%	4.03
	8176770	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	20.6	CHEMBL3290	Homo sapiens	Inhibition	%	20.6
	8176900	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.16	CHEMBL3290	Homo sapiens	Inhibition	%	-0.16
	8177266	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	15.12	CHEMBL3290	Homo sapiens	Inhibition	%	15.12
	8177404	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.57	CHEMBL3290	Homo sapiens	Inhibition	%	-0.57
	8177628	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.73	CHEMBL3290	Homo sapiens	Inhibition	%	10.73
	8177792	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	30.38	CHEMBL3290	Homo sapiens	Inhibition	%	30.38
	8178156	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	11.03	CHEMBL3290	Homo sapiens	Inhibition	%	11.03
	8178244	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	16.25	CHEMBL3290	Homo sapiens	Inhibition	%	16.25
	8178468	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	9.47	CHEMBL3290	Homo sapiens	Inhibition	%	9.47
	8178595	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	56.39	CHEMBL3290	Homo sapiens	Inhibition	%	56.39
	8178968	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	11.84	CHEMBL3290	Homo sapiens	Inhibition	%	11.84
	8179091	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	8.39	CHEMBL3290	Homo sapiens	Inhibition	%	8.39
	8179459	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.03	CHEMBL3290	Homo sapiens	Inhibition	%	4.03
	8179596	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	14.45	CHEMBL3290	Homo sapiens	Inhibition	%	14.45
	8179820	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.71	CHEMBL3290	Homo sapiens	Inhibition	%	4.71
	8180077	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.92	CHEMBL3290	Homo sapiens	Inhibition	%	4.92
	8180231	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	37.82	CHEMBL3290	Homo sapiens	Inhibition	%	37.82
	8180611	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.48	CHEMBL3290	Homo sapiens	Inhibition	%	8.48
	8180759	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.5	CHEMBL3290	Homo sapiens	Inhibition	%	3.5
	8181116	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	83.63	CHEMBL3290	Homo sapiens	Inhibition	%	83.63
	8181247	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.77	CHEMBL3290	Homo sapiens	Inhibition	%	0.77
	8181471	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-3.98	CHEMBL3290	Homo sapiens	Inhibition	%	-3.98
	8181611	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	61.46	CHEMBL3290	Homo sapiens	Inhibition	%	61.46
	8181974	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	17.62	CHEMBL3290	Homo sapiens	Inhibition	%	17.62
	8182137	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	9.15	CHEMBL3290	Homo sapiens	Inhibition	%	9.15
	8182501	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	8.38	CHEMBL3290	Homo sapiens	Inhibition	%	8.38
	8182817	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	14.09	CHEMBL3290	Homo sapiens	Inhibition	%	14.09
	8182939	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.53	CHEMBL3290	Homo sapiens	Inhibition	%	5.53
	8183312	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	9.46	CHEMBL3290	Homo sapiens	Inhibition	%	9.46
	8183441	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.8	CHEMBL3290	Homo sapiens	Inhibition	%	4.8
	8183665	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.69	CHEMBL3290	Homo sapiens	Inhibition	%	3.69
	8183807	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	11.09	CHEMBL3290	Homo sapiens	Inhibition	%	11.09
	8184167	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.21	CHEMBL3290	Homo sapiens	Inhibition	%	5.21
	8184433	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.41	CHEMBL3290	Homo sapiens	Inhibition	%	3.41
	8184580	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.52	CHEMBL3290	Homo sapiens	Inhibition	%	1.52
	8184804	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	6.05	CHEMBL3290	Homo sapiens	Inhibition	%	6.05
	8184961	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	34.26	CHEMBL3290	Homo sapiens	Inhibition	%	34.26
	8185110	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.77	CHEMBL3290	Homo sapiens	Inhibition	%	5.77
	8185334	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.63	CHEMBL3290	Homo sapiens	Inhibition	%	0.63
	8185465	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	86.35	CHEMBL3290	Homo sapiens	Inhibition	%	86.35
	8185820	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.51	CHEMBL3290	Homo sapiens	Inhibition	%	-0.51
	8185959	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.68	CHEMBL3290	Homo sapiens	Inhibition	%	6.68
	8186183	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	17.15	CHEMBL3290	Homo sapiens	Inhibition	%	17.15
	8186324	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.75	CHEMBL3290	Homo sapiens	Inhibition	%	7.75
	8186488	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	15.19	CHEMBL3290	Homo sapiens	Inhibition	%	15.19
	8186712	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	11.0	CHEMBL3290	Homo sapiens	Inhibition	%	11.0
	8186851	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.54	CHEMBL3290	Homo sapiens	Inhibition	%	6.54
	8187173	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	16.32	CHEMBL3290	Homo sapiens	Inhibition	%	16.32
	8187297	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	11.35	CHEMBL3290	Homo sapiens	Inhibition	%	11.35
	8187521	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.72	CHEMBL3290	Homo sapiens	Inhibition	%	5.72
	8187669	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	24.28	CHEMBL3290	Homo sapiens	Inhibition	%	24.28
	8188022	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	36.72	CHEMBL3290	Homo sapiens	Inhibition	%	36.72
	8188165	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.99	CHEMBL3290	Homo sapiens	Inhibition	%	3.99
	8188389	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.46	CHEMBL3290	Homo sapiens	Inhibition	%	6.46
	8188524	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	5.46	CHEMBL3290	Homo sapiens	Inhibition	%	5.46
	8188798	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.55	CHEMBL3290	Homo sapiens	Inhibition	%	6.55
	8189170	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	5.57	CHEMBL3290	Homo sapiens	Inhibition	%	5.57
	8189326	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	73.57	CHEMBL3290	Homo sapiens	Inhibition	%	73.57
	8189699	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.33	CHEMBL3290	Homo sapiens	Inhibition	%	-0.33
	8189831	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	10.27	CHEMBL3290	Homo sapiens	Inhibition	%	10.27
	8190187	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.05	CHEMBL3290	Homo sapiens	Inhibition	%	6.05
	8190551	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	16.48	CHEMBL3290	Homo sapiens	Inhibition	%	16.48
	8190688	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	18.59	CHEMBL3290	Homo sapiens	Inhibition	%	18.59
	8191076	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	11.26	CHEMBL3290	Homo sapiens	Inhibition	%	11.26
	8191214	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	10.55	CHEMBL3290	Homo sapiens	Inhibition	%	10.55
	8191534	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	56.66	CHEMBL3290	Homo sapiens	Inhibition	%	56.66
	8191880	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	14.89	CHEMBL3290	Homo sapiens	Inhibition	%	14.89
	8192029	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	7.22	CHEMBL3290	Homo sapiens	Inhibition	%	7.22
	8192253	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	11.11	CHEMBL3290	Homo sapiens	Inhibition	%	11.11
	8192382	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	7.58	CHEMBL3290	Homo sapiens	Inhibition	%	7.58
	8192750	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	7.84	CHEMBL3290	Homo sapiens	Inhibition	%	7.84
	8192886	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	11.49	CHEMBL3290	Homo sapiens	Inhibition	%	11.49
	8193158	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.32	CHEMBL3290	Homo sapiens	Inhibition	%	7.32
	8193527	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	30.43	CHEMBL3290	Homo sapiens	Inhibition	%	30.43
	8193684	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	9.06	CHEMBL3290	Homo sapiens	Inhibition	%	9.06
	8193908	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	10.77	CHEMBL3290	Homo sapiens	Inhibition	%	10.77
	8194057	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.18	CHEMBL3290	Homo sapiens	Inhibition	%	-2.18
	8194188	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	19.37	CHEMBL3290	Homo sapiens	Inhibition	%	19.37
	8194412	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	11.09	CHEMBL3290	Homo sapiens	Inhibition	%	11.09
	8194543	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.78	CHEMBL3290	Homo sapiens	Inhibition	%	7.78
	8194910	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	57.73	CHEMBL3290	Homo sapiens	Inhibition	%	57.73
	8195043	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.26	CHEMBL3290	Homo sapiens	Inhibition	%	8.26
	8195267	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	10.66	CHEMBL3290	Homo sapiens	Inhibition	%	10.66
	8195431	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	10.65	CHEMBL3290	Homo sapiens	Inhibition	%	10.65
	8195570	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	15.13	CHEMBL3290	Homo sapiens	Inhibition	%	15.13
	8195794	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	12.19	CHEMBL3290	Homo sapiens	Inhibition	%	12.19
	8195892	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	8.47	CHEMBL3290	Homo sapiens	Inhibition	%	8.47
	8196233	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.45	CHEMBL3290	Homo sapiens	Inhibition	%	8.45
	8196607	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	24.87	CHEMBL3290	Homo sapiens	Inhibition	%	24.87
	8196735	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	10.63	CHEMBL3290	Homo sapiens	Inhibition	%	10.63
	8197100	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	19.69	CHEMBL3290	Homo sapiens	Inhibition	%	19.69
	8197237	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	3.54	CHEMBL3290	Homo sapiens	Inhibition	%	3.54
	8197461	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	8.72	CHEMBL3290	Homo sapiens	Inhibition	%	8.72
	8197512	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.78	CHEMBL3290	Homo sapiens	Inhibition	%	5.78
	8197736	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	8.83	CHEMBL3290	Homo sapiens	Inhibition	%	8.83
	8197876	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.0	CHEMBL3290	Homo sapiens	Inhibition	%	2.0
	8198257	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.72	CHEMBL3290	Homo sapiens	Inhibition	%	3.72
	8198395	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.7	CHEMBL3290	Homo sapiens	Inhibition	%	-2.7
	8198749	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	41.35	CHEMBL3290	Homo sapiens	Inhibition	%	41.35
	8198880	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.72	CHEMBL3290	Homo sapiens	Inhibition	%	5.72
	8199104	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	12.58	CHEMBL3290	Homo sapiens	Inhibition	%	12.58
	8199252	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	9.32	CHEMBL3290	Homo sapiens	Inhibition	%	9.32
	8199610	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	8.04	CHEMBL3290	Homo sapiens	Inhibition	%	8.04
	8199773	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	14.97	CHEMBL3290	Homo sapiens	Inhibition	%	14.97
	8200135	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	11.39	CHEMBL3290	Homo sapiens	Inhibition	%	11.39
	8200239	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	8.11	CHEMBL3290	Homo sapiens	Inhibition	%	8.11
	8200463	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	8.11	CHEMBL3290	Homo sapiens	Inhibition	%	8.11
	8200578	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	12.77	CHEMBL3290	Homo sapiens	Inhibition	%	12.77
	8200952	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	70.64	CHEMBL3290	Homo sapiens	Inhibition	%	70.64
	8201082	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	7.38	CHEMBL3290	Homo sapiens	Inhibition	%	7.38
	8201306	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	20.8	CHEMBL3290	Homo sapiens	Inhibition	%	20.8
	8201441	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	7.31	CHEMBL3290	Homo sapiens	Inhibition	%	7.31
	8201798	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.99	CHEMBL3290	Homo sapiens	Inhibition	%	1.99
	8202077	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.21	CHEMBL3290	Homo sapiens	Inhibition	%	4.21
	8202217	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.08	CHEMBL3290	Homo sapiens	Inhibition	%	7.08
	8202608	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	7.66	CHEMBL3290	Homo sapiens	Inhibition	%	7.66
	8202733	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.6	CHEMBL3290	Homo sapiens	Inhibition	%	3.6
	8202957	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	10.63	CHEMBL3290	Homo sapiens	Inhibition	%	10.63
	8203087	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.07	CHEMBL3290	Homo sapiens	Inhibition	%	7.07
	8203442	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	5.88	CHEMBL3290	Homo sapiens	Inhibition	%	5.88
	8203588	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	15.3	CHEMBL3290	Homo sapiens	Inhibition	%	15.3
	8203946	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	11.29	CHEMBL3290	Homo sapiens	Inhibition	%	11.29
	8204112	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	22.99	CHEMBL3290	Homo sapiens	Inhibition	%	22.99
	8204336	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	67.95	CHEMBL3290	Homo sapiens	Inhibition	%	67.95
	8204473	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	90.49	CHEMBL3290	Homo sapiens	Inhibition	%	90.49
	8204802	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	55.39	CHEMBL3290	Homo sapiens	Inhibition	%	55.39
	8204917	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	11.7	CHEMBL3290	Homo sapiens	Inhibition	%	11.7
	8205141	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	38.72	CHEMBL3290	Homo sapiens	Inhibition	%	38.72
	8205290	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.24	CHEMBL3290	Homo sapiens	Inhibition	%	10.24
	8205650	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.96	CHEMBL3290	Homo sapiens	Inhibition	%	9.96
	8205789	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	12.56	CHEMBL3290	Homo sapiens	Inhibition	%	12.56
	8206145	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	19.69	CHEMBL3290	Homo sapiens	Inhibition	%	19.69
	8206421	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.49	CHEMBL3290	Homo sapiens	Inhibition	%	4.49
	8206564	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-3.26	CHEMBL3290	Homo sapiens	Inhibition	%	-3.26
	8206788	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.17	CHEMBL3290	Homo sapiens	Inhibition	%	-1.17
	8206968	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.03	CHEMBL3290	Homo sapiens	Inhibition	%	3.03
	8207318	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	6.05	CHEMBL3290	Homo sapiens	Inhibition	%	6.05
	8207448	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	11.59	CHEMBL3290	Homo sapiens	Inhibition	%	11.59
	8207804	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	23.27	CHEMBL3290	Homo sapiens	Inhibition	%	23.27
	8207949	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	6.81	CHEMBL3290	Homo sapiens	Inhibition	%	6.81
	8208173	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	9.04	CHEMBL3290	Homo sapiens	Inhibition	%	9.04
	8208305	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.99	CHEMBL3290	Homo sapiens	Inhibition	%	7.99
	8208695	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.74	CHEMBL3290	Homo sapiens	Inhibition	%	7.74
	8208828	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	91.9	CHEMBL3290	Homo sapiens	Inhibition	%	91.9
	8209157	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	5.91	CHEMBL3290	Homo sapiens	Inhibition	%	5.91
	8209497	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.32	CHEMBL3290	Homo sapiens	Inhibition	%	5.32
	8209647	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.21	CHEMBL3290	Homo sapiens	Inhibition	%	9.21
	8210007	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	13.14	CHEMBL3290	Homo sapiens	Inhibition	%	13.14
	8210148	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.33	CHEMBL3290	Homo sapiens	Inhibition	%	6.33
	8210372	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	11.57	CHEMBL3290	Homo sapiens	Inhibition	%	11.57
	8210508	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.13	CHEMBL3290	Homo sapiens	Inhibition	%	-2.13
	8210767	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.73	CHEMBL3290	Homo sapiens	Inhibition	%	2.73
	8211135	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.43	CHEMBL3290	Homo sapiens	Inhibition	%	6.43
	8211305	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.68	CHEMBL3290	Homo sapiens	Inhibition	%	5.68
	8211652	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	15.52	CHEMBL3290	Homo sapiens	Inhibition	%	15.52
	8211781	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	11.92	CHEMBL3290	Homo sapiens	Inhibition	%	11.92
	8212005	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	37.78	CHEMBL3290	Homo sapiens	Inhibition	%	37.78
	8212137	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.23	CHEMBL3290	Homo sapiens	Inhibition	%	4.23
	8212502	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.99	CHEMBL3290	Homo sapiens	Inhibition	%	6.99
	8212635	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	10.19	CHEMBL3290	Homo sapiens	Inhibition	%	10.19
	8212859	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	11.12	CHEMBL3290	Homo sapiens	Inhibition	%	11.12
	8213029	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	8.42	CHEMBL3290	Homo sapiens	Inhibition	%	8.42
	8213158	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	10.46	CHEMBL3290	Homo sapiens	Inhibition	%	10.46
	8213382	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	14.17	CHEMBL3290	Homo sapiens	Inhibition	%	14.17
	8213486	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	11.9	CHEMBL3290	Homo sapiens	Inhibition	%	11.9
	8213823	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.51	CHEMBL3290	Homo sapiens	Inhibition	%	3.51
	8213970	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	7.57	CHEMBL3290	Homo sapiens	Inhibition	%	7.57
	8214194	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	8.86	CHEMBL3290	Homo sapiens	Inhibition	%	8.86
	8214331	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	16.56	CHEMBL3290	Homo sapiens	Inhibition	%	16.56
	8214689	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	8.62	CHEMBL3290	Homo sapiens	Inhibition	%	8.62
	8214841	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.96	CHEMBL3290	Homo sapiens	Inhibition	%	1.96
	8215092	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.23	CHEMBL3290	Homo sapiens	Inhibition	%	2.23
	8215316	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.96	CHEMBL3290	Homo sapiens	Inhibition	%	4.96
	8215469	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	10.28	CHEMBL3290	Homo sapiens	Inhibition	%	10.28
	8215633	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.25	CHEMBL3290	Homo sapiens	Inhibition	%	5.25
	8215857	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.17	CHEMBL3290	Homo sapiens	Inhibition	%	4.17
	8215976	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.1	CHEMBL3290	Homo sapiens	Inhibition	%	3.1
	8216319	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.67	CHEMBL3290	Homo sapiens	Inhibition	%	5.67
	8216455	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	9.74	CHEMBL3290	Homo sapiens	Inhibition	%	9.74
	8216817	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.07	CHEMBL3290	Homo sapiens	Inhibition	%	7.07
	8217175	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	9.32	CHEMBL3290	Homo sapiens	Inhibition	%	9.32
	8217349	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	7.5	CHEMBL3290	Homo sapiens	Inhibition	%	7.5
	8217704	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	13.98	CHEMBL3290	Homo sapiens	Inhibition	%	13.98
	8217805	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.68	CHEMBL3290	Homo sapiens	Inhibition	%	-0.68
	8218029	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.8	CHEMBL3290	Homo sapiens	Inhibition	%	1.8
	8218144	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.22	CHEMBL3290	Homo sapiens	Inhibition	%	5.22
	8218495	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	14.07	CHEMBL3290	Homo sapiens	Inhibition	%	14.07
	8218638	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	21.91	CHEMBL3290	Homo sapiens	Inhibition	%	21.91
	8218993	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	38.58	CHEMBL3290	Homo sapiens	Inhibition	%	38.58
	8219153	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.38	CHEMBL3290	Homo sapiens	Inhibition	%	0.38
	8219377	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.59	CHEMBL3290	Homo sapiens	Inhibition	%	5.59
	8219627	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	7.41	CHEMBL3290	Homo sapiens	Inhibition	%	7.41
	8219788	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.53	CHEMBL3290	Homo sapiens	Inhibition	%	4.53
	8220181	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.86	CHEMBL3290	Homo sapiens	Inhibition	%	6.86
	8220310	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.9	CHEMBL3290	Homo sapiens	Inhibition	%	6.9
	8220648	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	7.8	CHEMBL3290	Homo sapiens	Inhibition	%	7.8
	8220786	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.53	CHEMBL3290	Homo sapiens	Inhibition	%	3.53
	8221010	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	9.85	CHEMBL3290	Homo sapiens	Inhibition	%	9.85
	8221146	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.91	CHEMBL3290	Homo sapiens	Inhibition	%	2.91
	8221503	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	9.96	CHEMBL3290	Homo sapiens	Inhibition	%	9.96
	8221668	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	9.65	CHEMBL3290	Homo sapiens	Inhibition	%	9.65
	8222023	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	35.96	CHEMBL3290	Homo sapiens	Inhibition	%	35.96
	8222345	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	9.45	CHEMBL3290	Homo sapiens	Inhibition	%	9.45
	8222479	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	11.67	CHEMBL3290	Homo sapiens	Inhibition	%	11.67
	8222821	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	46.38	CHEMBL3290	Homo sapiens	Inhibition	%	46.38
	8222965	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	85.67	CHEMBL3290	Homo sapiens	Inhibition	%	85.67
	8223189	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	89.9	CHEMBL3290	Homo sapiens	Inhibition	%	89.9
	8223318	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	13.66	CHEMBL3290	Homo sapiens	Inhibition	%	13.66
	8223703	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.4	CHEMBL3290	Homo sapiens	Inhibition	%	1.4
	8223953	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.7	CHEMBL3290	Homo sapiens	Inhibition	%	4.7
	8224115	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.88	CHEMBL3290	Homo sapiens	Inhibition	%	7.88
	8224339	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.55	CHEMBL3290	Homo sapiens	Inhibition	%	4.55
	8224509	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	7.17	CHEMBL3290	Homo sapiens	Inhibition	%	7.17
	8224644	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.68	CHEMBL3290	Homo sapiens	Inhibition	%	2.68
	8224868	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	10.24	CHEMBL3290	Homo sapiens	Inhibition	%	10.24
	8224982	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.63	CHEMBL3290	Homo sapiens	Inhibition	%	1.63
	8225340	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.18	CHEMBL3290	Homo sapiens	Inhibition	%	6.18
	8225478	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.79	CHEMBL3290	Homo sapiens	Inhibition	%	3.79
	8225702	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.03	CHEMBL3290	Homo sapiens	Inhibition	%	1.03
	8225837	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	12.59	CHEMBL3290	Homo sapiens	Inhibition	%	12.59
	8225995	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	5.6	CHEMBL3290	Homo sapiens	Inhibition	%	5.6
	8226219	CHEMBL1962275	GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	16.96	CHEMBL3290	Homo sapiens	Inhibition	%	16.96
	8226344	CHEMBL1962274	GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	9.67	CHEMBL3290	Homo sapiens	Inhibition	%	9.67
	10838576	CHEMBL2014149	Inhibition of EPHB2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	10839631	CHEMBL2015954	Inhibition of EPH-B2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	83.0	CHEMBL3290	Homo sapiens	Activity	%	83.0
	10839645	CHEMBL2015011	Inhibition of EPH-B2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	23.0	CHEMBL3290	Homo sapiens	Activity	%	23.0
	12046293	CHEMBL2156530	Inhibition of EphB2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	7.2	CHEMBL3290	Homo sapiens	INH	%	7.2
	12074676	CHEMBL2161397	Inhibition of EphB2 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	12170815	CHEMBL2210339	Inhibition of EPH-B2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	123.0	CHEMBL3290	Homo sapiens	Activity	%	123.0
	12172116	CHEMBL2213941	Inhibition of EPH-B2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	115.0	CHEMBL3290	Homo sapiens	Activity	%	115.0
	12173631	CHEMBL2214007	Inhibition of EPHB2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	71.0	CHEMBL3290	Homo sapiens	Activity	%	71.0
	12183891	CHEMBL2211496	Inhibition of EPHB2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	pIC50		5.0
	12223003	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12223004	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12223005	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12223006	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	102.0	CHEMBL3290	Homo sapiens	Residual Activity	%	102.0
	12223007	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	94.0	CHEMBL3290	Homo sapiens	Residual Activity	%	94.0
	12223008	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12223009	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	73.0	CHEMBL3290	Homo sapiens	Residual Activity	%	73.0
	12223010	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	92.0	CHEMBL3290	Homo sapiens	Residual Activity	%	92.0
	12223011	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	117.0	CHEMBL3290	Homo sapiens	Residual Activity	%	117.0
	12223012	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	77.0	CHEMBL3290	Homo sapiens	Residual Activity	%	77.0
	12223013	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12223014	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12223015	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	105.0	CHEMBL3290	Homo sapiens	Residual Activity	%	105.0
	12223016	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	3.0	CHEMBL3290	Homo sapiens	Residual Activity	%	3.0
	12223017	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12223018	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	118.0	CHEMBL3290	Homo sapiens	Residual Activity	%	118.0
	12223019	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	136.0	CHEMBL3290	Homo sapiens	Residual Activity	%	136.0
	12223020	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12223021	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	122.0	CHEMBL3290	Homo sapiens	Residual Activity	%	122.0
	12223022	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12223023	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12223024	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	105.0	CHEMBL3290	Homo sapiens	Residual Activity	%	105.0
	12223025	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12223026	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	114.0	CHEMBL3290	Homo sapiens	Residual Activity	%	114.0
	12223027	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12223028	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	46.0	CHEMBL3290	Homo sapiens	Residual Activity	%	46.0
	12223029	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	88.0	CHEMBL3290	Homo sapiens	Residual Activity	%	88.0
	12223030	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	65.0	CHEMBL3290	Homo sapiens	Residual Activity	%	65.0
	12223031	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	114.0	CHEMBL3290	Homo sapiens	Residual Activity	%	114.0
	12225398	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225399	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225400	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-2.0	CHEMBL3290	Homo sapiens	Residual Activity	%	-2.0
	12225401	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	119.0	CHEMBL3290	Homo sapiens	Residual Activity	%	119.0
	12225402	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12225403	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225404	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225405	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225406	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225407	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	125.0	CHEMBL3290	Homo sapiens	Residual Activity	%	125.0
	12225408	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225409	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	122.0	CHEMBL3290	Homo sapiens	Residual Activity	%	122.0
	12225410	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	117.0	CHEMBL3290	Homo sapiens	Residual Activity	%	117.0
	12225411	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12225412	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225413	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225414	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225415	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	122.0	CHEMBL3290	Homo sapiens	Residual Activity	%	122.0
	12225416	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225417	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	126.0	CHEMBL3290	Homo sapiens	Residual Activity	%	126.0
	12225418	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	130.0	CHEMBL3290	Homo sapiens	Residual Activity	%	130.0
	12225419	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12225420	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225421	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	87.0	CHEMBL3290	Homo sapiens	Residual Activity	%	87.0
	12225422	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225423	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225424	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12225425	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12225426	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	130.0	CHEMBL3290	Homo sapiens	Residual Activity	%	130.0
	12225427	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225428	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12225429	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	102.0	CHEMBL3290	Homo sapiens	Residual Activity	%	102.0
	12225430	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225431	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225432	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12225433	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	117.0	CHEMBL3290	Homo sapiens	Residual Activity	%	117.0
	12225434	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225435	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225436	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225437	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	98.0	CHEMBL3290	Homo sapiens	Residual Activity	%	98.0
	12225438	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225439	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	117.0	CHEMBL3290	Homo sapiens	Residual Activity	%	117.0
	12225440	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	93.0	CHEMBL3290	Homo sapiens	Residual Activity	%	93.0
	12225441	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	119.0	CHEMBL3290	Homo sapiens	Residual Activity	%	119.0
	12225442	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	118.0	CHEMBL3290	Homo sapiens	Residual Activity	%	118.0
	12225443	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12225444	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	91.0	CHEMBL3290	Homo sapiens	Residual Activity	%	91.0
	12225445	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225446	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	89.0	CHEMBL3290	Homo sapiens	Residual Activity	%	89.0
	12225447	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12225448	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	20.0	CHEMBL3290	Homo sapiens	Residual Activity	%	20.0
	12225449	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225450	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225451	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12225452	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	90.0	CHEMBL3290	Homo sapiens	Residual Activity	%	90.0
	12225453	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225454	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL3290	Homo sapiens	Residual Activity	%	107.0
	12225455	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225456	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225457	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225458	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	91.0	CHEMBL3290	Homo sapiens	Residual Activity	%	91.0
	12225459	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	114.0	CHEMBL3290	Homo sapiens	Residual Activity	%	114.0
	12225460	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	117.0	CHEMBL3290	Homo sapiens	Residual Activity	%	117.0
	12225461	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	100.0	CHEMBL3290	Homo sapiens	Residual Activity	%	100.0
	12225462	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225463	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225464	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225465	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225466	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	122.0	CHEMBL3290	Homo sapiens	Residual Activity	%	122.0
	12225467	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	123.0	CHEMBL3290	Homo sapiens	Residual Activity	%	123.0
	12225468	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	123.0	CHEMBL3290	Homo sapiens	Residual Activity	%	123.0
	12225469	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225470	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	114.0	CHEMBL3290	Homo sapiens	Residual Activity	%	114.0
	12225471	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	118.0	CHEMBL3290	Homo sapiens	Residual Activity	%	118.0
	12225472	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	104.0	CHEMBL3290	Homo sapiens	Residual Activity	%	104.0
	12225473	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12225474	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225475	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12225476	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	114.0	CHEMBL3290	Homo sapiens	Residual Activity	%	114.0
	12225477	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225478	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225479	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225480	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	36.0	CHEMBL3290	Homo sapiens	Residual Activity	%	36.0
	12225481	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	104.0	CHEMBL3290	Homo sapiens	Residual Activity	%	104.0
	12225482	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225483	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225484	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225485	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	93.0	CHEMBL3290	Homo sapiens	Residual Activity	%	93.0
	12225486	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225487	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	98.0	CHEMBL3290	Homo sapiens	Residual Activity	%	98.0
	12225488	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225489	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	96.0	CHEMBL3290	Homo sapiens	Residual Activity	%	96.0
	12225490	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	56.0	CHEMBL3290	Homo sapiens	Residual Activity	%	56.0
	12225491	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	102.0	CHEMBL3290	Homo sapiens	Residual Activity	%	102.0
	12225492	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12225493	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	82.0	CHEMBL3290	Homo sapiens	Residual Activity	%	82.0
	12225494	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225495	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	71.0	CHEMBL3290	Homo sapiens	Residual Activity	%	71.0
	12225496	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225497	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225498	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	72.0	CHEMBL3290	Homo sapiens	Residual Activity	%	72.0
	12225499	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12225500	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	105.0	CHEMBL3290	Homo sapiens	Residual Activity	%	105.0
	12225501	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225502	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	102.0	CHEMBL3290	Homo sapiens	Residual Activity	%	102.0
	12225503	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	4.0	CHEMBL3290	Homo sapiens	Residual Activity	%	4.0
	12225504	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	92.0	CHEMBL3290	Homo sapiens	Residual Activity	%	92.0
	12225505	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225506	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225507	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	33.0	CHEMBL3290	Homo sapiens	Residual Activity	%	33.0
	12225508	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225509	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225510	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12225511	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	105.0	CHEMBL3290	Homo sapiens	Residual Activity	%	105.0
	12225512	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	25.0	CHEMBL3290	Homo sapiens	Residual Activity	%	25.0
	12225513	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL3290	Homo sapiens	Residual Activity	%	96.0
	12225514	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225515	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225516	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	107.0	CHEMBL3290	Homo sapiens	Residual Activity	%	107.0
	12225517	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	89.0	CHEMBL3290	Homo sapiens	Residual Activity	%	89.0
	12225518	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12225519	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225520	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	122.0	CHEMBL3290	Homo sapiens	Residual Activity	%	122.0
	12225521	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12225522	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225523	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225524	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225525	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	94.0	CHEMBL3290	Homo sapiens	Residual Activity	%	94.0
	12225526	CHEMBL2219052	Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	99.0	CHEMBL3290	Homo sapiens	Residual Activity	%	99.0
	12225527	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225528	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	92.0	CHEMBL3290	Homo sapiens	Residual Activity	%	92.0
	12225529	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	99.0	CHEMBL3290	Homo sapiens	Residual Activity	%	99.0
	12225530	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	64.0	CHEMBL3290	Homo sapiens	Residual Activity	%	64.0
	12225531	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	62.0	CHEMBL3290	Homo sapiens	Residual Activity	%	62.0
	12225532	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12225533	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	49.0	CHEMBL3290	Homo sapiens	Residual Activity	%	49.0
	12225534	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	19.0	CHEMBL3290	Homo sapiens	Residual Activity	%	19.0
	12225535	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	107.0	CHEMBL3290	Homo sapiens	Residual Activity	%	107.0
	12225536	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	5.0	CHEMBL3290	Homo sapiens	Residual Activity	%	5.0
	12225537	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	107.0	CHEMBL3290	Homo sapiens	Residual Activity	%	107.0
	12225538	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225539	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	55.0	CHEMBL3290	Homo sapiens	Residual Activity	%	55.0
	12225540	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	-1.0	CHEMBL3290	Homo sapiens	Residual Activity	%	-1.0
	12225541	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	87.0	CHEMBL3290	Homo sapiens	Residual Activity	%	87.0
	12225542	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	105.0	CHEMBL3290	Homo sapiens	Residual Activity	%	105.0
	12225543	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	129.0	CHEMBL3290	Homo sapiens	Residual Activity	%	129.0
	12225544	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225545	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225546	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225547	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	131.0	CHEMBL3290	Homo sapiens	Residual Activity	%	131.0
	12225548	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	69.0	CHEMBL3290	Homo sapiens	Residual Activity	%	69.0
	12225549	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	124.0	CHEMBL3290	Homo sapiens	Residual Activity	%	124.0
	12225550	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	97.0	CHEMBL3290	Homo sapiens	Residual Activity	%	97.0
	12225551	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12225552	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	0.0	CHEMBL3290	Homo sapiens	Residual Activity	%	0.0
	12225553	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	24.0	CHEMBL3290	Homo sapiens	Residual Activity	%	24.0
	12225554	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	1.0	CHEMBL3290	Homo sapiens	Residual Activity	%	1.0
	12225555	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	137.0	CHEMBL3290	Homo sapiens	Residual Activity	%	137.0
	12225556	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	122.0	CHEMBL3290	Homo sapiens	Residual Activity	%	122.0
	12225557	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225558	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL3290	Homo sapiens	Residual Activity	%	-1.0
	12225559	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	90.0	CHEMBL3290	Homo sapiens	Residual Activity	%	90.0
	12225560	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	124.0	CHEMBL3290	Homo sapiens	Residual Activity	%	124.0
	12225561	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	129.0	CHEMBL3290	Homo sapiens	Residual Activity	%	129.0
	12225562	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225563	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	64.0	CHEMBL3290	Homo sapiens	Residual Activity	%	64.0
	12225564	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	105.0	CHEMBL3290	Homo sapiens	Residual Activity	%	105.0
	12225565	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	131.0	CHEMBL3290	Homo sapiens	Residual Activity	%	131.0
	12225566	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12225567	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225568	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12225569	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225570	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12225571	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	136.0	CHEMBL3290	Homo sapiens	Residual Activity	%	136.0
	12225572	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225573	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL3290	Homo sapiens	Residual Activity	%	102.0
	12225574	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	97.0	CHEMBL3290	Homo sapiens	Residual Activity	%	97.0
	12225575	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	138.0	CHEMBL3290	Homo sapiens	Residual Activity	%	138.0
	12225576	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL3290	Homo sapiens	Residual Activity	%	102.0
	12225577	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	88.0	CHEMBL3290	Homo sapiens	Residual Activity	%	88.0
	12225578	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225579	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	29.0	CHEMBL3290	Homo sapiens	Residual Activity	%	29.0
	12225580	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	93.0	CHEMBL3290	Homo sapiens	Residual Activity	%	93.0
	12225581	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	124.0	CHEMBL3290	Homo sapiens	Residual Activity	%	124.0
	12225582	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12225583	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	118.0	CHEMBL3290	Homo sapiens	Residual Activity	%	118.0
	12225584	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12225585	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12225586	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	104.0	CHEMBL3290	Homo sapiens	Residual Activity	%	104.0
	12225587	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL3290	Homo sapiens	Residual Activity	%	75.0
	12225588	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	222.0	CHEMBL3290	Homo sapiens	Residual Activity	%	222.0
	12225589	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225590	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225591	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	136.0	CHEMBL3290	Homo sapiens	Residual Activity	%	136.0
	12225592	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	130.0	CHEMBL3290	Homo sapiens	Residual Activity	%	130.0
	12225593	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	128.0	CHEMBL3290	Homo sapiens	Residual Activity	%	128.0
	12225594	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12225595	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	119.0	CHEMBL3290	Homo sapiens	Residual Activity	%	119.0
	12225596	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12225597	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225598	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	26.0	CHEMBL3290	Homo sapiens	Residual Activity	%	26.0
	12225599	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12225600	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	114.0	CHEMBL3290	Homo sapiens	Residual Activity	%	114.0
	12225601	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	94.0	CHEMBL3290	Homo sapiens	Residual Activity	%	94.0
	12225602	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	68.0	CHEMBL3290	Homo sapiens	Residual Activity	%	68.0
	12225603	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225604	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	36.0	CHEMBL3290	Homo sapiens	Residual Activity	%	36.0
	12225605	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12225606	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3290	Homo sapiens	Residual Activity	%	0.0
	12225607	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	131.0	CHEMBL3290	Homo sapiens	Residual Activity	%	131.0
	12225608	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	68.0	CHEMBL3290	Homo sapiens	Residual Activity	%	68.0
	12225609	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	101.0	CHEMBL3290	Homo sapiens	Residual Activity	%	101.0
	12225610	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	92.0	CHEMBL3290	Homo sapiens	Residual Activity	%	92.0
	12225611	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	107.0	CHEMBL3290	Homo sapiens	Residual Activity	%	107.0
	12225612	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12225613	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	107.0	CHEMBL3290	Homo sapiens	Residual Activity	%	107.0
	12225614	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	61.0	CHEMBL3290	Homo sapiens	Residual Activity	%	61.0
	12225615	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	126.0	CHEMBL3290	Homo sapiens	Residual Activity	%	126.0
	12225616	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	13.0	CHEMBL3290	Homo sapiens	Residual Activity	%	13.0
	12225617	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	118.0	CHEMBL3290	Homo sapiens	Residual Activity	%	118.0
	12225618	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12225619	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	48.0	CHEMBL3290	Homo sapiens	Residual Activity	%	48.0
	12225620	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	103.0	CHEMBL3290	Homo sapiens	Residual Activity	%	103.0
	12225621	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12225622	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225623	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	139.0	CHEMBL3290	Homo sapiens	Residual Activity	%	139.0
	12225624	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	126.0	CHEMBL3290	Homo sapiens	Residual Activity	%	126.0
	12225625	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12225626	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	128.0	CHEMBL3290	Homo sapiens	Residual Activity	%	128.0
	12225627	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	92.0	CHEMBL3290	Homo sapiens	Residual Activity	%	92.0
	12225628	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	55.0	CHEMBL3290	Homo sapiens	Residual Activity	%	55.0
	12225629	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	132.0	CHEMBL3290	Homo sapiens	Residual Activity	%	132.0
	12225630	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12227999	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	107.0	CHEMBL3290	Homo sapiens	Residual Activity	%	107.0
	12228000	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12228001	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12228002	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12228003	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	116.0	CHEMBL3290	Homo sapiens	Residual Activity	%	116.0
	12228004	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12228005	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12228006	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	31.0	CHEMBL3290	Homo sapiens	Residual Activity	%	31.0
	12228007	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	67.0	CHEMBL3290	Homo sapiens	Residual Activity	%	67.0
	12228008	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12228009	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	128.0	CHEMBL3290	Homo sapiens	Residual Activity	%	128.0
	12228010	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	121.0	CHEMBL3290	Homo sapiens	Residual Activity	%	121.0
	12228011	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	19.0	CHEMBL3290	Homo sapiens	Residual Activity	%	19.0
	12228012	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	120.0	CHEMBL3290	Homo sapiens	Residual Activity	%	120.0
	12228013	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	28.0	CHEMBL3290	Homo sapiens	Residual Activity	%	28.0
	12228014	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	91.0	CHEMBL3290	Homo sapiens	Residual Activity	%	91.0
	12228015	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	82.0	CHEMBL3290	Homo sapiens	Residual Activity	%	82.0
	12228016	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	0.0	CHEMBL3290	Homo sapiens	Residual Activity	%	0.0
	12228017	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	35.0	CHEMBL3290	Homo sapiens	Residual Activity	%	35.0
	12228018	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12228019	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	12.0	CHEMBL3290	Homo sapiens	Residual Activity	%	12.0
	12228020	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12228021	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	3.0	CHEMBL3290	Homo sapiens	Residual Activity	%	3.0
	12228022	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12228023	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	89.0	CHEMBL3290	Homo sapiens	Residual Activity	%	89.0
	12228024	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	3.0	CHEMBL3290	Homo sapiens	Residual Activity	%	3.0
	12228025	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	106.0	CHEMBL3290	Homo sapiens	Residual Activity	%	106.0
	12228026	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	117.0	CHEMBL3290	Homo sapiens	Residual Activity	%	117.0
	12228027	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	95.0	CHEMBL3290	Homo sapiens	Residual Activity	%	95.0
	12228028	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12228029	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-1.0	CHEMBL3290	Homo sapiens	Residual Activity	%	-1.0
	12228030	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	7.0	CHEMBL3290	Homo sapiens	Residual Activity	%	7.0
	12228031	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	111.0	CHEMBL3290	Homo sapiens	Residual Activity	%	111.0
	12228032	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	32.0	CHEMBL3290	Homo sapiens	Residual Activity	%	32.0
	12228033	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	22.0	CHEMBL3290	Homo sapiens	Residual Activity	%	22.0
	12228034	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12228035	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12228036	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	105.0	CHEMBL3290	Homo sapiens	Residual Activity	%	105.0
	12228037	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	108.0	CHEMBL3290	Homo sapiens	Residual Activity	%	108.0
	12228038	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	0.0	CHEMBL3290	Homo sapiens	Residual Activity	%	0.0
	12228039	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	24.0	CHEMBL3290	Homo sapiens	Residual Activity	%	24.0
	12228040	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	109.0	CHEMBL3290	Homo sapiens	Residual Activity	%	109.0
	12228041	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	60.0	CHEMBL3290	Homo sapiens	Residual Activity	%	60.0
	12228042	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	85.0	CHEMBL3290	Homo sapiens	Residual Activity	%	85.0
	12228043	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	9.0	CHEMBL3290	Homo sapiens	Residual Activity	%	9.0
	12228044	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	115.0	CHEMBL3290	Homo sapiens	Residual Activity	%	115.0
	12228045	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	97.0	CHEMBL3290	Homo sapiens	Residual Activity	%	97.0
	12228046	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	110.0	CHEMBL3290	Homo sapiens	Residual Activity	%	110.0
	12228047	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	112.0	CHEMBL3290	Homo sapiens	Residual Activity	%	112.0
	12228048	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	104.0	CHEMBL3290	Homo sapiens	Residual Activity	%	104.0
	12228049	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	113.0	CHEMBL3290	Homo sapiens	Residual Activity	%	113.0
	12228050	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	93.0	CHEMBL3290	Homo sapiens	Residual Activity	%	93.0
	12228051	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	43.0	CHEMBL3290	Homo sapiens	Residual Activity	%	43.0
	12228052	CHEMBL2219053	Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	100.0	CHEMBL3290	Homo sapiens	Residual Activity	%	100.0
	12649136	CHEMBL2329867	Displacement of ephrin-B1-Fc from EphB2 receptor Fc ectodomain (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	3800.0	CHEMBL3290	Homo sapiens	IC50	uM	3.8
	12673053	CHEMBL2340168	Inhibition of recombinant EPH-B2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	2.0	CHEMBL3290	Homo sapiens	Activity	%	2.0
	12673054	CHEMBL2340168	Inhibition of recombinant EPH-B2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	2.0	CHEMBL3290	Homo sapiens	Activity	%	2.0
	12674219	CHEMBL2344194	Inhibition of human Eph-B2 using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	8.0	CHEMBL3290	Homo sapiens	Activity	%	8.0
Active	12688502	CHEMBL2339603	Agonist activity at IgG1 Fc region fused-immobilized EphB2 (unknown origin) assessed as inhibition of EphB2/ephrin-B2 AP interaction at 10 uM incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337010		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
	12728842	CHEMBL2352915	Inhibition of EPHB2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	88.0	CHEMBL3290	Homo sapiens	Activity	%	88.0
	12729971	CHEMBL2352207	Inhibition of EPHB2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL3290	Homo sapiens	Activity	%	95.0
	12729982	CHEMBL2352265	Inhibition of EPHB2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL3290	Homo sapiens	Activity	%	99.0
	12730230	CHEMBL2352915	Inhibition of EPHB2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL3290	Homo sapiens	Activity	%	99.0
	13375873	CHEMBL2405135	Inhibition of EPHB2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	5.0	CHEMBL3290	Homo sapiens	INH	%	5.0
	13436566	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13436567	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13436568	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13436569	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13436570	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13436571	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13436572	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13438051	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13438052	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13438053	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13438054	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13438055	CHEMBL2422437	Inhibition of EphB2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	13439853	CHEMBL2427154	Competitive binding affinity to EPHB2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	13445386	CHEMBL2427154	Competitive binding affinity to EPHB2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	13445686	CHEMBL2427154	Competitive binding affinity to EPHB2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	13451673	CHEMBL2427154	Competitive binding affinity to EPHB2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	13499579	CHEMBL2447145	Inhibition of EPHB2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL3290	Homo sapiens	IC50	nM	1000.0
	13872155	CHEMBL3101780	Inhibition of human EphB2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	127.0	CHEMBL3290	Homo sapiens	Activity	%	127.0
Not Active	14545568	CHEMBL3225614	Binding affinity to human EphB2 (amino acid residues V27 to K458) at 0.125 to 2 uM by surface plasmon resonance assay	B	CCCCCCCCCCCCCCCCCC(=O)OCC(CO[C@@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC.[Na+]		CHEMBL3219622		Activity			CHEMBL3290	Homo sapiens	Activity		
	14582491	CHEMBL3242343	Inhibition of human EphB2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	94.5	CHEMBL3290	Homo sapiens	Activity	%	94.5
	15072603	CHEMBL3382663	Inhibition of EPHB2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	114.0	CHEMBL3290	Homo sapiens	Activity	%	114.0
	15249761	CHEMBL3429407	Inhibition of recombinant EphB2 (unknown origin) by cell-free assay	B	[2H]C([2H])([2H])Oc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC([2H])([2H])[2H]		CHEMBL3426917	=	IC50	nM	26.8	CHEMBL3290	Homo sapiens	IC50	nM	26.8
	15249762	CHEMBL3429407	Inhibition of recombinant EphB2 (unknown origin) by cell-free assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	IC50	nM	17.5	CHEMBL3290	Homo sapiens	IC50	nM	17.5
	15253817	CHEMBL3429877	Inhibition of human EphB2	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	26.0	CHEMBL3290	Homo sapiens	IC50	uM	0.026
	15655490	CHEMBL3598607	Inhibition of EphB2 (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2cncc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4C)cc3)n2)cn1		CHEMBL3596893	=	IC50	nM	2200.0	CHEMBL3290	Homo sapiens	IC50	uM	2.2
	15655491	CHEMBL3598607	Inhibition of EphB2 (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2cncc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)no4)cc3)n2)cn1		CHEMBL3596892	=	IC50	nM	2900.0	CHEMBL3290	Homo sapiens	IC50	uM	2.9
	15655492	CHEMBL3598607	Inhibition of EphB2 (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cncc(-c4ccc(F)cc4)n3)c2)no1		CHEMBL3596889	>	IC50	nM	2000.0	CHEMBL3290	Homo sapiens	IC50	uM	2.0
	15655493	CHEMBL3598607	Inhibition of EphB2 (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cn1		CHEMBL3596879	=	IC50	nM	880.0	CHEMBL3290	Homo sapiens	IC50	uM	0.88
	15655494	CHEMBL3598607	Inhibition of EphB2 (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cncc(-c4ccc(S(C)(=O)=O)cc4)n3)c2)no1		CHEMBL3596873	>	IC50	nM	2000.0	CHEMBL3290	Homo sapiens	IC50	uM	2.0
	15655495	CHEMBL3598607	Inhibition of EphB2 (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cncc(-c4ccsc4)n3)c2)no1		CHEMBL3596868	>	IC50	nM	2000.0	CHEMBL3290	Homo sapiens	IC50	uM	2.0
	15655496	CHEMBL3598607	Inhibition of EphB2 (unknown origin) using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	B	COc1ccc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cc1		CHEMBL3596862	>	IC50	nM	2000.0	CHEMBL3290	Homo sapiens	IC50	uM	2.0
	15736004	CHEMBL3625836	Inhibition of human recombinant EphB2	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	uM	10.0
	15756999	CHEMBL3630484	Inhibition of EPHB2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	97.73	CHEMBL3290	Homo sapiens	INH	%	97.73
	15757724	CHEMBL3630484	Inhibition of EPHB2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	74.93	CHEMBL3290	Homo sapiens	INH	%	74.93
	15758703	CHEMBL3630484	Inhibition of EPHB2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	20.27	CHEMBL3290	Homo sapiens	INH	%	20.27
Dose-dependent effect	16392483	CHEMBL3738310	Displacement of biotinylated ephrin-B1-Fc from EphB2 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
	16392520	CHEMBL3738310	Displacement of biotinylated ephrin-B1-Fc from EphB2 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	5400.0	CHEMBL3290	Homo sapiens	IC50	uM	5.4
	16431820	CHEMBL3748174	Inhibition of human EPHB2 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3290	Homo sapiens	IC50	uM	10.0
	16450834	CHEMBL3762690	Inhibition of EPHB2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	15.3	CHEMBL3290	Homo sapiens	INH	%	15.3
	16495984	CHEMBL3778575	Inhibition of N-terminal His6-tagged recombinant human EPHB2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-16.0	CHEMBL3290	Homo sapiens	Activity	%	-16.0
	16508171	CHEMBL3778575	Inhibition of N-terminal His6-tagged recombinant human EPHB2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	25.0	CHEMBL3290	Homo sapiens	Activity	%	25.0
	16509148	CHEMBL3778575	Inhibition of N-terminal His6-tagged recombinant human EPHB2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	14.0	CHEMBL3290	Homo sapiens	Activity	%	14.0
	16574800	CHEMBL3802408	Inhibition of recombinant EPHB2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	8.5	CHEMBL3290	Homo sapiens	INH	%	8.5
	16593605	CHEMBL3811563	Inhibition of GST-tagged human recombinant EPHB2 (616 to 884 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	>=	Inhibition	%	80.0	CHEMBL3290	Homo sapiens	INH	%	80.0
	16611856	CHEMBL3816750	Inhibition of human EPHB2 (560 to 987 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	15.0	CHEMBL3290	Homo sapiens	Activity	%	15.0
	16614465	CHEMBL3816595	Inhibition of human EPHB2 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-18.0	CHEMBL3290	Homo sapiens	INH	%	-18.0
	16618227	CHEMBL3816228	Inhibition of recombinant human GST-tagged cytoplasmic EPHB2 (616 to 884 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	16621491	CHEMBL3820484	Inhibition of EPHB2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL3290	Homo sapiens	IC50	nM	30000.0
	16622206	CHEMBL3820484	Inhibition of EPHB2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	198.8	CHEMBL3290	Homo sapiens	IC50	nM	198.8
	16654251	CHEMBL3829897	Inhibition of human EPHB2 (560 to 987 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	81.0	CHEMBL3290	Homo sapiens	Activity	%	81.0
	16837413	CHEMBL3876084	Inhibition of human recombinant GST-tagged EPHB2 cytoplasmic domain (616 to 884 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	2158.0	CHEMBL3290	Homo sapiens	IC50	nM	2158.0
Inactive	17900310	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900311	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900312	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900313	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900314	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900315	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900316	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900317	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900318	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900319	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900320	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900321	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	2236.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	2236.0
Inactive	17900322	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900323	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900324	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900325	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	302.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	302.0
Inactive	17900326	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900327	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900328	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900329	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900330	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900331	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900332	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	4.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	4.0
Inactive	17900333	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900334	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900335	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900336	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900337	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900338	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900339	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900340	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900341	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900342	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900343	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900344	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900345	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900346	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900347	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900348	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900349	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900350	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900351	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900352	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900353	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900354	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900355	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900356	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900357	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900358	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900359	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900360	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900361	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900362	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900363	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900364	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900365	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900366	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900367	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900368	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900369	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900370	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900371	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900372	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	1857.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	1857.0
Inactive	17900373	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900374	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900375	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900376	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	2.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	2.0
Inactive	17900377	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900378	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900379	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	669.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	669.0
Inactive	17900380	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900381	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900382	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900383	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900384	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900385	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900386	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900387	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900388	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900389	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900390	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900391	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900392	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900393	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900394	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900395	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900396	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	63.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	63.0
Active	17900397	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	259.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	259.0
Inactive	17900398	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900399	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900400	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900401	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900402	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900403	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900404	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900405	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900406	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900407	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900408	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900409	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900410	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900411	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900412	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900413	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900414	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900415	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900416	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900417	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900418	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900419	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900420	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900421	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900422	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900423	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900424	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900425	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900426	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900427	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900428	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900429	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900430	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900431	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900432	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900433	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	9415.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	9415.0
Active	17900434	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	149.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	149.0
Inactive	17900435	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900436	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900437	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	53198.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	53198.0
Inactive	17900438	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900439	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900440	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	448.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	448.0
Inactive	17900441	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900442	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900443	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900444	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900445	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900446	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900447	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900448	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900449	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900450	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	448.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	448.0
Inactive	17900451	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900452	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17900453	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	2282.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	2282.0
Inactive	17900454	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900455	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900456	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900457	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900458	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900459	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900460	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900461	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900462	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900463	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900464	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	2506.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	2506.0
Inactive	17900465	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900466	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900467	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900468	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900469	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900470	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900471	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900472	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900473	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900474	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900475	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	767.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	767.0
Inactive	17900476	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900477	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900478	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900479	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900480	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900481	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900482	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900483	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900484	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900485	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900486	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900487	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900488	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900489	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900490	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	7565.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	7565.0
Inactive	17900491	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900492	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900493	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900494	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900495	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900496	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900497	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900498	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900499	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900500	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900501	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900502	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900503	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900504	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900505	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900506	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900507	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900508	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900509	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900510	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900511	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900512	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900513	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900514	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900515	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900516	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900517	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900518	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900519	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900520	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900521	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900522	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900523	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900524	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900525	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900526	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900527	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900528	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900529	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900530	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900531	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900532	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900533	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	1296.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	1296.0
Inactive	17900534	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900535	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900536	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900537	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900538	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900539	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900540	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900541	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900542	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900543	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900544	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900545	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900546	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900547	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900548	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900549	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900550	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900551	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	30000.0
Active	17900552	CHEMBL3991705	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	5029.0	CHEMBL3290	Homo sapiens	Kd apparent	nM	5029.0
	18053074	CHEMBL4011854	Inhibition of EPHB2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-0.3	CHEMBL3290	Homo sapiens	INH	%	-0.3
	18096348	CHEMBL4021235	Inhibition of EPHB2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	>	IC50	nM	30000.0	CHEMBL3290	Homo sapiens	IC50	nM	30000.0
	18114372	CHEMBL4025122	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3290	Homo sapiens	Activity	%	100.0
	18138935	CHEMBL4030444	Inhibition of EphB2 (unknown origin) at 10 uM relative to control	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	Inhibition	%	60.0	CHEMBL3290	Homo sapiens	INH	%	60.0
	18153320	CHEMBL4034319	Inhibition of EphB2 activation loop (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-11.7	CHEMBL3290	Homo sapiens	INH	%	-11.7
	18203646	CHEMBL4043933	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	99.0	CHEMBL3290	Homo sapiens	Activity	%	99.0
	18232110	CHEMBL4050392	Inhibition of human EPH-B2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	96.0	CHEMBL3290	Homo sapiens	Activity	%	96.0
	18248588	CHEMBL4053871	Inhibition of EPHB2 (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	6.0	CHEMBL3290	Homo sapiens	INH	%	6.0
	18253509	CHEMBL4055038	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	85.0	CHEMBL3290	Homo sapiens	Activity	%	85.0
	18253510	CHEMBL4055038	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3290	Homo sapiens	Activity	%	100.0
	18265782	CHEMBL4057232	Inhibition of EPHB2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	6.7	CHEMBL3290	Homo sapiens	INH	%	6.7
	18265980	CHEMBL4057430	Inhibition of EPHB2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	5.3	CHEMBL3290	Homo sapiens	INH	%	5.3
	18274872	CHEMBL4118336	Inhibition of EphB2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FLEDDTSDPTYTSALGGKIPIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-17.5	CHEMBL3290	Homo sapiens	INH	%	-17.5
	18274873	CHEMBL4118336	Inhibition of EphB2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FLEDDTSDPTYTSALGGKIPIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	13.7	CHEMBL3290	Homo sapiens	INH	%	13.7
	18274874	CHEMBL4118336	Inhibition of EphB2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FLEDDTSDPTYTSALGGKIPIR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	24.2	CHEMBL3290	Homo sapiens	INH	%	24.2
	18282751	CHEMBL4120336	Inhibition of EPHB2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	6.7	CHEMBL3290	Homo sapiens	INH	%	6.7
	18282978	CHEMBL4120563	Inhibition of EPHB2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	4.0	CHEMBL3290	Homo sapiens	INH	%	4.0
	18283202	CHEMBL4120787	Inhibition of EPHB2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-1.0	CHEMBL3290	Homo sapiens	INH	%	-1.0
	18409085	CHEMBL4151619	Inhibition of EPHB2 (unknown origin) at 1 uM	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	>	Inhibition	%	90.0	CHEMBL3290	Homo sapiens	INH	%	90.0
	18409097	CHEMBL4151631	Binding affinity to human EPHB2	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	=	Kd	nM	260.0	CHEMBL3290	Homo sapiens	Kd	nM	260.0
	18440188	CHEMBL4157012	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3290	Homo sapiens	Activity	%	100.0
	18449911	CHEMBL4178147	Inhibition of human EPHB2 (560 to 987 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	95.0	CHEMBL3290	Homo sapiens	Activity	%	95.0
	18463745	CHEMBL4181161	Inhibition of recombinant human N-terminal His6-tagged EphB2 (560 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	7.0	CHEMBL3290	Homo sapiens	INH	%	7.0
	18484628	CHEMBL4185791	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	93.0	CHEMBL3290	Homo sapiens	Activity	%	93.0
	18484993	CHEMBL4185791	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL3290	Homo sapiens	Activity	%	96.0
	18507800	CHEMBL4190962	Inhibition of recombinant human EPHB2 (560 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	2.0	CHEMBL3290	Homo sapiens	INH	%	2.0
	18577628	CHEMBL4222214	Inhibition of recombinant human GST-tagged EPHB2 cytoplasmic domain (616 to 884 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	8.5	CHEMBL3290	Homo sapiens	INH	%	8.5
	18577652	CHEMBL4222214	Inhibition of recombinant human GST-tagged EPHB2 cytoplasmic domain (616 to 884 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	1.6	CHEMBL3290	Homo sapiens	INH	%	1.6
	18577676	CHEMBL4222214	Inhibition of recombinant human GST-tagged EPHB2 cytoplasmic domain (616 to 884 residues) expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	3.5	CHEMBL3290	Homo sapiens	INH	%	3.5
	18653653	CHEMBL4230077	Inhibition of EPH-B2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL3290	Homo sapiens	INH	%	99.0
	18653654	CHEMBL4230077	Inhibition of EPH-B2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	97.0	CHEMBL3290	Homo sapiens	INH	%	97.0
	18655544	CHEMBL4230691	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL3290	Homo sapiens	Activity	%	100.0
	18665537	CHEMBL4233315	Inhibition of EPH-B2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL3290	Homo sapiens	IC50	nM	1000.0
	18674643	CHEMBL4235348	Inhibition of EphB2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL3290	Homo sapiens	Ki	nM	2000.0
	18674644	CHEMBL4235348	Inhibition of EphB2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL3290	Homo sapiens	Ki	nM	2000.0
Not Determined	18674645	CHEMBL4235348	Inhibition of EphB2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL3290	Homo sapiens	Ki		
	18693982	CHEMBL4253435	Inhibition of recombinant human GST-tagged EPHB2 cytoplasmic domain (616 to 884 residues) expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-8.0	CHEMBL3290	Homo sapiens	INH	%	-8.0
	18694064	CHEMBL4253517	Inhibition of recombinant human GST-tagged EPHB2 cytoplasmic domain (616 to 884 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	3.0	CHEMBL3290	Homo sapiens	INH	%	3.0
	18751119	CHEMBL4263795	Inhibition of EPH-B2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	18751623	CHEMBL4264280	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	82.0	CHEMBL3290	Homo sapiens	Activity	%	82.0
	18784713	CHEMBL4271242	Binding affinity to EphB2 (unknown origin) by SPR assay	B	CC(=O)NCSC[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC1CCCCC1)C(=O)N1[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@H](CSCNC(C)=O)C(=O)N[C@H](CCCCN)C(=O)O)[C@@H](C)O)C[C@@H]2CCCC[C@@H]21)C(C)(C)C		CHEMBL4276804	=	Kd	nM	12.0	CHEMBL3290	Homo sapiens	Kd	nM	12.0
	18857949	CHEMBL4307795	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	97.0	CHEMBL3290	Homo sapiens	Activity	%	97.0
	18919365	CHEMBL4322739	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHB2 (unknown origin) (581 to 986 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	985.0	CHEMBL3290	Homo sapiens	Kd	nM	985.0
Not Determined	18919379	CHEMBL4322739	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHB2 (unknown origin) (581 to 986 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489		Kd			CHEMBL3290	Homo sapiens	Kd		
	18937901	CHEMBL4327681	Inhibition of human EPHB2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.52	CHEMBL3290	Homo sapiens	Activity	%	101.52
	18937902	CHEMBL4327681	Inhibition of human EPHB2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	105.41	CHEMBL3290	Homo sapiens	Activity	%	105.41
	18938521	CHEMBL4328041	Inhibition of human EPHB2 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3290	Homo sapiens	Activity	%	65.0
	18938899	CHEMBL4328405	Inhibition of human EPHB2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	116.0	CHEMBL3290	Homo sapiens	IC50	10'-7M	1.16
	18958866	CHEMBL4333385	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	79.0	CHEMBL3290	Homo sapiens	Activity	%	79.0
Active	19041099	CHEMBL4352360	Inhibition of human EPHB2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3290	Homo sapiens	INH		
	19059568	CHEMBL4357869	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	59.0	CHEMBL3290	Homo sapiens	Activity	%	59.0
	19090139	CHEMBL4365713	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3290	Homo sapiens	Activity	%	100.0
	19091914	CHEMBL4366388	Inhibition of human EPHB2 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-6.07	CHEMBL3290	Homo sapiens	INH	%	-6.07
	19159396	CHEMBL4382500	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	61.0	CHEMBL3290	Homo sapiens	Activity	%	61.0
	19191611	CHEMBL4389219	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	69.0	CHEMBL3290	Homo sapiens	INH	%	69.0
	19191882	CHEMBL4389696	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	85.0	CHEMBL3290	Homo sapiens	INH	%	85.0
	19199900	CHEMBL4391322	Binding affinity to wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	61.0	CHEMBL3290	Homo sapiens	Activity	%	61.0
	19236739	CHEMBL4398812	Inhibition of EPHB2 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL3290	Homo sapiens	INH	%	25.0
	19266410	CHEMBL4405360	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3290	Homo sapiens	INH	%	50.0
	19275988	CHEMBL4407991	Inhibition of recombinant human EPhB2 (560 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	23.0	CHEMBL3290	Homo sapiens	INH	%	23.0
	19295869	CHEMBL4412346	Inhibition of EPH-B2 (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	86.9	CHEMBL3290	Homo sapiens	INH	%	86.9
	19295899	CHEMBL4412376	Inhibition of EPH-B2 (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	76.7	CHEMBL3290	Homo sapiens	INH	%	76.7
	19295929	CHEMBL4412406	Inhibition of EPH-B2 (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	48.0	CHEMBL3290	Homo sapiens	INH	%	48.0
	19475362	CHEMBL4479457	Inhibition of human EPHB2	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL3290	Homo sapiens	IC50	nM	30000.0
	19476570	CHEMBL4479718	Inhibition of recombinant human GST-tagged cytoplasmic EPHB2 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	<	IC50	nM	10.0	CHEMBL3290	Homo sapiens	IC50	nM	10.0
	19476670	CHEMBL4479718	Inhibition of recombinant human GST-tagged cytoplasmic EPHB2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	36.0	CHEMBL3290	Homo sapiens	IC50	nM	36.0
	19476770	CHEMBL4479718	Inhibition of recombinant human GST-tagged cytoplasmic EPHB2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	2.9	CHEMBL3290	Homo sapiens	IC50	nM	2.9
	19476870	CHEMBL4479718	Inhibition of recombinant human GST-tagged cytoplasmic EPHB2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	3800.0	CHEMBL3290	Homo sapiens	IC50	nM	3800.0
	20598190	CHEMBL4602919	Inhibition of human EPHB2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL3290	Homo sapiens	IC50	uM	1.0
	20600521	CHEMBL4603473	Inhibition of recombinant human GST-tagged EPHB2 catalytic domain (616 to 884 residues) expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3290	Homo sapiens	IC50	uM	100.0
	20608954	CHEMBL4605665	Inhibition of EPHB2 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	IC50	nM	93.2	CHEMBL3290	Homo sapiens	IC50	uM	0.0932
	20608965	CHEMBL4605654	Inhibition of EPHB2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	Activity	%	2.0	CHEMBL3290	Homo sapiens	Activity	%	2.0
	20609002	CHEMBL4605654	Inhibition of EPHB2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	Activity	%	1.0	CHEMBL3290	Homo sapiens	Activity	%	1.0
	20609013	CHEMBL4605665	Inhibition of EPHB2 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	IC50	nM	70.8	CHEMBL3290	Homo sapiens	IC50	uM	0.0708
	20609034	CHEMBL4605654	Inhibition of EPHB2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Activity	%	25.0	CHEMBL3290	Homo sapiens	Activity	%	25.0
	20609050	CHEMBL4605654	Inhibition of EPHB2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Activity	%	2.0	CHEMBL3290	Homo sapiens	Activity	%	2.0
	22391680	CHEMBL4666966	Inhibition of recombinant human GST-tagged EPHB2 (616 to 884 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	10.0	CHEMBL3290	Homo sapiens	INH	%	10.0
	22391681	CHEMBL4666966	Inhibition of recombinant human GST-tagged EPHB2 (616 to 884 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	1.0	CHEMBL3290	Homo sapiens	INH	%	1.0
	22391682	CHEMBL4666966	Inhibition of recombinant human GST-tagged EPHB2 (616 to 884 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	-3.0	CHEMBL3290	Homo sapiens	INH	%	-3.0
	22423643	CHEMBL4674397	Inhibition of human EPHB2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	70.83	CHEMBL3290	Homo sapiens	Activity	%	70.83
	22423644	CHEMBL4674397	Inhibition of human EPHB2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	85.73	CHEMBL3290	Homo sapiens	Activity	%	85.73
	22826323	CHEMBL4717508	Inhibition of N-terminal His6-tagged human EphB2 (560 to end residues) expressed in baculovirus-infected Sf21 cells assessed as residual activity at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Activity	%	60.0	CHEMBL3290	Homo sapiens	Activity	%	60.0
	22843759	CHEMBL4720745	Inhibition of human EPHB2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	42.4	CHEMBL3290	Homo sapiens	IC50	10^-8M	4.24
	22844111	CHEMBL4721097	Inhibition of human EPHB2 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	80.49	CHEMBL3290	Homo sapiens	Activity	%	80.49
	22844698	CHEMBL4721373	Inhibition of wild-type human partial length EPHB2 (I597 to L902 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	95.29	CHEMBL3290	Homo sapiens	Activity	%	95.29
	22952829	CHEMBL4766766	Inhibition of recombinant human EphB2 (560 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	3.0	CHEMBL3290	Homo sapiens	Activity	%	3.0
	22953089	CHEMBL4767026	Inhibition of recombinant human EphB2 (560 to end residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	1090.0	CHEMBL3290	Homo sapiens	IC50	uM	1.09
	23120362	CHEMBL4804376	Inhibition of EpHB2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	22100.0	CHEMBL3290	Homo sapiens	IC50	uM	22.1
	23120363	CHEMBL4804376	Inhibition of EpHB2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-2000.0	CHEMBL3290	Homo sapiens	IC50	uM	-2.0
	23120364	CHEMBL4804376	Inhibition of EpHB2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	29000.0	CHEMBL3290	Homo sapiens	IC50	uM	29.0
	23120365	CHEMBL4804376	Inhibition of EpHB2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	8800.0	CHEMBL3290	Homo sapiens	IC50	uM	8.8
	23120366	CHEMBL4804376	Inhibition of EpHB2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	20300.0	CHEMBL3290	Homo sapiens	IC50	uM	20.3
	23120367	CHEMBL4804376	Inhibition of EpHB2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-25000.0	CHEMBL3290	Homo sapiens	IC50	uM	-25.0
	23121402	CHEMBL4804558	Inhibition of EpHB2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	23121403	CHEMBL4804558	Inhibition of EpHB2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	23121404	CHEMBL4804558	Inhibition of EpHB2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	23121405	CHEMBL4804558	Inhibition of EpHB2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	23121406	CHEMBL4804558	Inhibition of EpHB2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	23121407	CHEMBL4804558	Inhibition of EpHB2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL3290	Homo sapiens	INH	%	0.0
	23122554	CHEMBL4804905	Inhibition of human EPHB2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	86.0	CHEMBL3290	Homo sapiens	Activity	%	86.0
	23123249	CHEMBL4805493	Inhibition of human EPHB2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	70.0	CHEMBL3290	Homo sapiens	Activity	%	70.0
	23123642	CHEMBL4805886	Inhibition of DNA-tagged human EPHB2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3290	Homo sapiens	Activity	%	100.0
	23124588	CHEMBL4806510	Inhibition of human EPHB2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL3290	Homo sapiens	Activity	%	99.0
	23124589	CHEMBL4806510	Inhibition of human EPHB2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	95.0	CHEMBL3290	Homo sapiens	Activity	%	95.0
	23127419	CHEMBL4807600	Inhibition of EPHB2 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	15.0	CHEMBL3290	Homo sapiens	Activity	%	15.0
	23127420	CHEMBL4807600	Inhibition of EPHB2 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	1.0	CHEMBL3290	Homo sapiens	Activity	%	1.0
	23128068	CHEMBL4807831	Inhibition of EPHB2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL3290	Homo sapiens	Activity	%	25.0
	23128069	CHEMBL4807831	Inhibition of EPHB2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL3290	Homo sapiens	Activity	%	25.0
	23128070	CHEMBL4807831	Inhibition of EPHB2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL3290	Homo sapiens	Activity	%	25.0
	23128783	CHEMBL4808061	Inhibition of EPHB2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	93.0	CHEMBL3290	Homo sapiens	INH	%	93.0
	23128784	CHEMBL4808061	Inhibition of EPHB2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	48.0	CHEMBL3290	Homo sapiens	INH	%	48.0
	23128785	CHEMBL4808061	Inhibition of EPHB2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	27.0	CHEMBL3290	Homo sapiens	INH	%	27.0
	23128786	CHEMBL4808061	Inhibition of EPHB2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3n[nH]nc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4853006	=	Inhibition	%	35.0	CHEMBL3290	Homo sapiens	INH	%	35.0
	23128787	CHEMBL4808061	Inhibition of EPHB2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(NC)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4855979	=	Inhibition	%	51.0	CHEMBL3290	Homo sapiens	INH	%	51.0
	23128788	CHEMBL4808061	Inhibition of EPHB2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	39.0	CHEMBL3290	Homo sapiens	INH	%	39.0
Not Active	23317389	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	76.0	CHEMBL3290	Homo sapiens	% Control	%	76.0
Not Active	23317857	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	99.0	CHEMBL3290	Homo sapiens	% Control	%	99.0
Not Active	23318526	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	94.0	CHEMBL3290	Homo sapiens	% Control	%	94.0
Not Active	23319007	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23319644	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23320119	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	73.0	CHEMBL3290	Homo sapiens	% Control	%	73.0
Not Active	23320797	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	98.0	CHEMBL3290	Homo sapiens	% Control	%	98.0
Not Active	23321265	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	99.0	CHEMBL3290	Homo sapiens	% Control	%	99.0
Not Active	23321895	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23322363	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23323052	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23323520	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	84.0	CHEMBL3290	Homo sapiens	% Control	%	84.0
Not Active	23324001	CHEMBL4880620	EphB2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-15.0	CHEMBL3290	Homo sapiens	% inhibition	%	-15.0
Not Active	23324374	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23325009	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23325477	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23326124	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23326592	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	74.0	CHEMBL3290	Homo sapiens	% Control	%	74.0
Not Active	23327292	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23327760	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23328347	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23328815	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	83.0	CHEMBL3290	Homo sapiens	% Control	%	83.0
Not Active	23329334	CHEMBL4881041	EphB2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	93.0	CHEMBL3290	Homo sapiens	% residual kinase activity	%	93.0
Not Active	23329761	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	78.0	CHEMBL3290	Homo sapiens	% Control	%	78.0
Not Active	23330229	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23330985	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23331453	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23332040	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	71.4	CHEMBL3290	Homo sapiens	% Control	%	71.4
Not Active	23332506	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23333224	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23333863	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23334331	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23334890	CHEMBL4881514	EphB2 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12	Outside typical range	CHEMBL1971943		Inhibition	%	-12.0	CHEMBL3290	Homo sapiens	% inhibition	%	-12.0
Not Active	23335310	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	99.0	CHEMBL3290	Homo sapiens	% Control	%	99.0
Not Active	23335778	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23336405	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23336873	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23337587	CHEMBL4881958	EPHB2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	93.5	CHEMBL3290	Homo sapiens	% Ctrl	%	93.5
Not Active	23337954	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	87.0	CHEMBL3290	Homo sapiens	% Control	%	87.0
Not Active	23338422	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	70.0	CHEMBL3290	Homo sapiens	% Control	%	70.0
Not Active	23339034	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23339502	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	95.0	CHEMBL3290	Homo sapiens	% Control	%	95.0
Not Active	23340139	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23340607	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	92.0	CHEMBL3290	Homo sapiens	% Control	%	92.0
Not Active	23341264	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23341732	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	82.0	CHEMBL3290	Homo sapiens	% Control	%	82.0
Not Active	23342348	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23342816	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	82.0	CHEMBL3290	Homo sapiens	% Control	%	82.0
Not Active	23343446	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23343914	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23344552	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	61.0	CHEMBL3290	Homo sapiens	% Control	%	61.0
Not Active	23345125	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	98.0	CHEMBL3290	Homo sapiens	% Control	%	98.0
Not Active	23345593	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	91.0	CHEMBL3290	Homo sapiens	% Control	%	91.0
Not Active	23346170	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23346639	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23347247	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	83.3	CHEMBL3290	Homo sapiens	% Control	%	83.3
Not Active	23347730	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23348309	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23348777	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23349364	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23349982	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23350450	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23351055	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23351523	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	87.0	CHEMBL3290	Homo sapiens	% Control	%	87.0
Not Active	23352038	CHEMBL4882729	EPHB2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-1.143	CHEMBL3290	Homo sapiens	% Inhibition	%	-1.1431
Not Active	23352547	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	90.0	CHEMBL3290	Homo sapiens	% Control	%	90.0
Not Active	23353015	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	95.0	CHEMBL3290	Homo sapiens	% Control	%	95.0
Not Active	23353897	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23354365	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	92.0	CHEMBL3290	Homo sapiens	% Control	%	92.0
Not Active	23355097	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	79.0	CHEMBL3290	Homo sapiens	% Control	%	79.0
Not Active	23355565	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	80.0	CHEMBL3290	Homo sapiens	% Control	%	80.0
Not Active	23356201	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	99.0	CHEMBL3290	Homo sapiens	% Control	%	99.0
Not Active	23356669	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	83.0	CHEMBL3290	Homo sapiens	% Control	%	83.0
Not Active	23357278	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	96.0	CHEMBL3290	Homo sapiens	% Control	%	96.0
Not Active	23357925	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23358393	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23358979	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	95.7	CHEMBL3290	Homo sapiens	% Control	%	95.7
Not Active	23359577	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	66.0	CHEMBL3290	Homo sapiens	% Control	%	66.0
Not Active	23360045	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	80.0	CHEMBL3290	Homo sapiens	% Control	%	80.0
Not Active	23360630	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23361098	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	87.0	CHEMBL3290	Homo sapiens	% Control	%	87.0
Not Active	23361671	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23362207	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23362675	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	86.0	CHEMBL3290	Homo sapiens	% Control	%	86.0
Not Active	23364317	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	75.0	CHEMBL3290	Homo sapiens	% Control	%	75.0
Not Active	23364785	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23365524	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23366067	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23366657	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23367125	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23367560	CHEMBL4883913	EPHB2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	91.0	CHEMBL3290	Homo sapiens	% Residual activity with Skepinone-L	%	91.0
Not Active	23368003	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	87.0	CHEMBL3290	Homo sapiens	% Control	%	87.0
Not Active	23368471	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	91.0	CHEMBL3290	Homo sapiens	% Control	%	91.0
Not Active	23369070	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	93.0	CHEMBL3290	Homo sapiens	% Control	%	93.0
Not Active	23369538	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23370056	CHEMBL4884300	EphB2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	98.0	CHEMBL3290	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23370506	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	76.0	CHEMBL3290	Homo sapiens	% Control	%	76.0
Not Active	23370974	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	86.0	CHEMBL3290	Homo sapiens	% Control	%	86.0
Not Active	23371783	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23372251	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	87.0	CHEMBL3290	Homo sapiens	% Control	%	87.0
	23372738	CHEMBL4884703	EphB2(EPB2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3290	Homo sapiens	pIC50		6.0
	23373147	CHEMBL4884994	EphB2(EPB2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3290	Homo sapiens	pIC50		6.0
	23373508	CHEMBL4885285	EphB2(EPB2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3290	Homo sapiens	pIC50		6.0
Not Active	23375242	CHEMBL4886224	EPH receptor B2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-18.0	CHEMBL3290	Homo sapiens	% inhibition	%	-18.0
Not Active	23375678	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	96.0	CHEMBL3290	Homo sapiens	% Control	%	96.0
Not Active	23376146	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	70.0	CHEMBL3290	Homo sapiens	% Control	%	70.0
Not Active	23376723	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23377192	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	71.0	CHEMBL3290	Homo sapiens	% Control	%	71.0
Not Active	23378051	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	72.0	CHEMBL3290	Homo sapiens	% Control	%	72.0
Not Active	23378519	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	87.0	CHEMBL3290	Homo sapiens	% Control	%	87.0
Not Active	23379686	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23380154	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	77.0	CHEMBL3290	Homo sapiens	% Control	%	77.0
Not Active	23380848	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23381496	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3290	Homo sapiens	% Control	%	100.0
Not Active	23381964	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	94.0	CHEMBL3290	Homo sapiens	% Control	%	94.0
Not Active	23382588	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	76.0	CHEMBL3290	Homo sapiens	% Control	%	76.0
Not Active	23383056	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	81.0	CHEMBL3290	Homo sapiens	% Control	%	81.0
Not Active	23383781	CHEMBL4887420	EPHB2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	89.0	CHEMBL3290	Homo sapiens	% Ctrl	%	89.0
Not Active	23384266	CHEMBL4887861	EphB2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	1.4	CHEMBL3290	Homo sapiens	% inhibition	%	1.4
Not Active	23384971	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	76.0	CHEMBL3290	Homo sapiens	% Control	%	76.0
Not Active	23385438	CHEMBL4879695	KinomeScan assay: inhibition of EPHB2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	92.0	CHEMBL3290	Homo sapiens	% Control	%	92.0
